SIK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A6NMY6 | S26 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| A6NMY6 | T163 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| A8MPP1 | S279 | Sugiyama | DDX11L8 | LVSLGSRQNLCVNEDVRSLGsVQLINDRCVDMQRSRHEKKK |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00165 | S162 | Sugiyama | HAX1 HS1BP1 | GGVLESDARSEsPQPAPDWGsQRPFHRFDDVWPMDPHPRtR |
| O00231 | S298 | Sugiyama | PSMD11 | RYAGRQTEALKCVAQASKNRsLADFEKALTDYRAELRDDPI |
| O00267 | Y802 | Sugiyama | SUPT5H SPT5 SPT5H | sRtPMYGsQtPLQDGsRtPHyGsQtPLHDGsRtPAQsGAWD |
| O00571 | S74 | Sugiyama | DDX3X DBX DDX3 | DKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGsGsRG |
| O00571 | S82 | Sugiyama | DDX3X DBX DDX3 | ssKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRs |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15085 | T1292 | Sugiyama | ARHGEF11 KIAA0380 | GERPEQEDMGLCSLEHLPPRtRNsGIWEsPELDRNLAEDAS |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15523 | S74 | Sugiyama | DDX3Y DBY | DKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSGSRGR |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60291 | S515 | Sugiyama | MGRN1 KIAA0544 RNF156 | sFItEEVDESssPQQGTRAAsIENVLQDssPEHCGRGPPAD |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75122 | S327 | Sugiyama | CLASP2 KIAA0627 | YLKssGsVAsLPQsDRsssssQEsLNRPFSSKWSTANPSTV |
| O75179 | S1457 | Sugiyama | ANKRD17 GTAR KIAA0697 | CMESIVQAKDRQAAEANKNAsILLEELDLEKLREESRRLAL |
| O75390 | S453 | Sugiyama | CS | LAQLIWSRALGFPLERPKSMsTEGLMKFVDSKSG_______ |
| O75643 | S17 | Sugiyama | SNRNP200 ASCC3L1 BRR2 HELIC2 KIAA0788 | ____MADVTARsLQYEYKANsNLVLQADRsLIDRTRRDEPT |
| O75822 | S127 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLtPEEQLADKLRLKKLQEEsDLELAKEtFGVNNAVyGIDA |
| O76003 | S117 | Sugiyama | GLRX3 PICOT TXNL2 HUSSY-22 | IDRLDGAHAPELTKKVQRHAssGsFLPSANEHLKEDLNLRL |
| O94826 | S91 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | RGDASGLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsL |
| O94979 | S799 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | IMQLRDRLCRAQGEPVAGHEsPKIPyEKQQLPKGRPGPVAG |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95218 | S75 | Sugiyama | ZRANB2 ZIS ZNF265 | tLAEKSRGLFsANDWQCKTCsNVNWARRsECNMCNtPKYAK |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04075 | S176 | Sugiyama | ALDOA ALDA | EHtPsALAIMENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | S26 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| P07355 | T163 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S40 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | FWEVISDEHGIDPTGtyHGDsDLQLDRIsVyyNEAtGGKyV |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P08195 | S252 | Sugiyama | SLC3A2 MDU1 | AFQGHGAGNLAGLKGRLDyLssLKVKGLVLGPIHKNQKDDV |
| P08195 | S286 | Sugiyama | SLC3A2 MDU1 | KNQKDDVAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVIL |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09884 | S1447 | Sugiyama | POLA1 POLA | LQDYRKLKNTAEQFLSRSGYsEVNLSKLFAGCAVKS_____ |
| P09923 | S189 | Sugiyama | ALPI | RVQHAsPAGtyAHtVNRNWysDADMPASARQEGCQDIATQL |
| P09972 | S176 | Sugiyama | ALDOC ALDC | ERTPSALAILENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10768 | S189 | Sugiyama | ESD | VSAFAPICNPVLCPWGKKAFsGyLGTDQsKWKAyDAtHLVK |
| P11142 | S329 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | LFRGtLDPVEKALRDAKLDKsQIHDIVLVGGstRIPKIQKL |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11279 | S141 | Sugiyama | LAMP1 | NLSDTHLFPNASSKEIKtVEsITDIRADIDKKYRCVSGTQV |
| P11388 | S390 | Sugiyama | TOP2A TOP2 | NPTFDSQTKENMTLQPKSFGsTCQLSEKFIKAAIGCGIVES |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P11532 | S3624 | Sugiyama | DMD | AKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEED |
| P11586 | S318 | Sugiyama | MTHFD1 MTHFC MTHFD | FKPGKWMIQYNNLNLKTPVPsDIDIsRSCKPKPIGKLAREI |
| P11586 | S765 | Sugiyama | MTHFD1 MTHFC MTHFD | ARMFGIPVVVAVNAFKTDTEsELDLIsRLSREHGAFDAVKC |
| P11717 | S1952 | Sugiyama | IGF2R MPRI | DYDRDHEWGFCRHSNSYRTssIIFKCDEDEDIGRPQVFSEV |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P13010 | Y316 | Sugiyama | XRCC5 G22P2 | CLNDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSE |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S124 | Sugiyama | PDIA4 ERP70 ERP72 | IANILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILK |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13797 | S540 | Sugiyama | PLS3 | NDDIIVNWVNRTLSEAGKSTsIQSFKDKTISSSLAVVDLID |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18031 | S15 | Sugiyama | PTPN1 PTP1B | ______MEMEKEFEQIDKsGsWAAIyQDIRHEASDFPCRVA |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P19174 | S672 | Sugiyama | PLCG1 PLC1 | RLSEPVPQTNAHESKEWYHAsLTRAQAEHMLMRVPRDGAFL |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P20020 | S52 | Sugiyama | ATP2B1 PMCA1 | AELRALMELRSTDALRKIQEsyGDVyGICTKLKTSPNEGLS |
| P21108 | S10 | Sugiyama | PRPS1L1 PRPS3 PRPSL | ___________MPNIKIFsGssHQDLSQKIADRLGLELGKV |
| P21108 | S11 | Sugiyama | PRPS1L1 PRPS3 PRPSL | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21333 | S2158 | Sugiyama | FLNA FLN FLN1 | GRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQDMtAQV |
| P22059 | S240 | Sugiyama | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P22059 | S386 | Sugiyama | OSBP OSBP1 | ITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLEETKKEKR |
| P22087 | S124 | Sugiyama | FBL FIB1 FLRN | DALVTKNLVPGEsVyGEKRVsIsEGDDKIEyRAWNPFRSKL |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S324 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNYNQQPSNYGPMKsGNFGGsRNMGGPyGGGNyGPGGsGGs |
| P23284 | S150 | Sugiyama | PPIB CYPB | LKHyGPGWVsMANAGKDTNGsQFFITTVKTAWLDGKHVVFG |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S406 | Sugiyama | EIF4B | KLQRQLDEPKLERRPRERHPsWRsEEtQERERsRtGsEssQ |
| P23588 | S597 | Sugiyama | EIF4B | KKPEENPASKFssASKyAALsVDGEDENEGEDyAE______ |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P26038 | S144 | Sugiyama | MSN | LLASyAVQSKYGDFNKEVHKsGYLAGDKLLPQRVLEQHKLN |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P28066 | S180 | Sugiyama | PSMA5 | GtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLI |
| P28838 | S180 | Sugiyama | LAP3 LAPEP PEPS | YEYDDLKQKKKMAVSAKLyGsGDQEAWQKGVLFAsGQNLAR |
| P28838 | S194 | Sugiyama | LAP3 LAPEP PEPS | SAKLyGsGDQEAWQKGVLFAsGQNLARQLMETPANEMTPtR |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30622 | S195 | Sugiyama | CLIP1 CYLN1 RSN | AAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIG |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31948 | S16 | Sugiyama | STIP1 | _____MEQVNELKEKGNKALsVGNIDDALQCysEAIKLDPH |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P34897 | S90 | Sugiyama | SHMT2 | GLELIAsENFCsRAALEALGsCLNNKYSEGYPGKRyyGGAE |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35241 | S532 | Sugiyama | RDX | EERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35568 | S794 | GPS6|ELM | IRS1 | tQRPGEPEEGARHQHLRLSTsSGRLLYAATADDSSSStSSD |
| P35606 | S350 | Sugiyama | COPB2 | MGDAEIKDGERLPLAVKDMGsCEIyPQtIQHNPNGRFVVVC |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P40818 | S718 | Sugiyama | USP8 KIAA0055 UBPY | AKPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtP |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46459 | S298 | Sugiyama | NSF | NAREPKVVNGPEILNKyVGEsEANIRKLFADAEEEQRRLGA |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P48637 | S276 | Sugiyama | GSS | VDGQEIAVVYFRDGYMPRQYsLQNWEARLLLERSHAAKCPD |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | S659 | Sugiyama | NASP | IEELKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsst |
| P49327 | S265 | Sugiyama | FASN FAS | TILNAGTNTDGFKEQGVtFPsGDIQEQLIRSLyQsAGVAPE |
| P49368 | T254 | Sugiyama | CCT3 CCTG TRIC5 | KNPRIVLLDssLEyKKGEsQtDIEITREEDFTRILQMEEEY |
| P49588 | S627 | Sugiyama | AARS1 AARS | ATHILNFALRSVLGEADQKGsLVAPDRLRFDFTAKGAMSTQ |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P51116 | S504 | Sugiyama | FXR2 FMR1L2 | PTGGRGRGPPPAPRPTSRYNsSsISSVLKDPDsNPYSLLDt |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P51991 | Y364 | Sugiyama | HNRNPA3 HNRPA3 | GPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF______ |
| P52272 | S365 | Sugiyama | HNRNPM HNRPM NAGR1 | KMGGMEGPFGGGMENMGRFGsGMNMGRINEILsNALKRGEI |
| P52272 | S432 | Sugiyama | HNRNPM HNRPM NAGR1 | GGAGMERMGAGLGHGMDRVGsEIERMGLVMDRMGsVERMGs |
| P52272 | S528 | Sugiyama | HNRNPM HNRPM NAGR1 | IERMGsGVERMGPAIERMGLsMERMVPAGMGAGLERMGPVM |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52597 | S63 | Sugiyama | HNRNPF HNRPF | VHFIYTREGRQsGEAFVELGsEDDVKMALKKDRESMGHRyI |
| P52788 | S57 | Sugiyama | SMS | ESVHTWQDHGYLATYTNKNGsFANLRIYPHGLVLLDLQSYD |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53621 | S389 | Sugiyama | COPA | SYNPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPE |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55196 | S216 | Sugiyama | AFDN AF6 MLLT4 | SRLAAEVYKDMPETSFTRtIsNPEVVMKRRRQQKLEKRMQE |
| P55769 | S122 | Sugiyama | SNU13 NHP2L1 | CSVTIKEGSQLKQQIQsIQQsIERLLV______________ |
| P56524 | S246 | GPS6 | HDAC4 KIAA0288 | NHPVLGMYDAKDDFPLRKTAsEPNLKLRSRLKQKVAERRss |
| P56524 | S467 | GPS6 | HDAC4 KIAA0288 | DRVSPSIHKLRQHRPLGRtQsAPLPQNAQALQHLVIQQQHQ |
| P57059 | S117 | Sugiyama | SIK1 SIK SNF1LK | DMLYIVTEFAKNGEMFDYLTsNGHLSENEARKKFWQILSAV |
| P57059 | S186 | GPS6|EPSD | SIK1 SIK SNF1LK | ADFGFGNFYKSGEPLStWCGsPPYAAPEVFEGKEYEGPQLD |
| P57059 | S463 | Sugiyama | SIK1 SIK SNF1LK | AISEEARQGPGLEEEQDtQEsLPSSTGRRHtLAEVSTRLSP |
| P57059 | S534 | Sugiyama | SIK1 SIK SNF1LK | SKsPAGLSGTPATQGLLGACsPVRLASPFLGSQSATPVLQA |
| P57059 | S575 | Sugiyama | SIK1 SIK SNF1LK | QGGLGGAVLLPVSFQEGRRAsDtSLtQGLKAFRQQLRKTTR |
| P57059 | S626 | Sugiyama | SIK1 SIK SNF1LK | KGLARQVCQAPASRASRGGLsPFHAPAQsPGLHGGAAGsRE |
| P57059 | S634 | Sugiyama | SIK1 SIK SNF1LK | QAPASRASRGGLsPFHAPAQsPGLHGGAAGsREGWSLLEEV |
| P57059 | S644 | Sugiyama | SIK1 SIK SNF1LK | GLsPFHAPAQsPGLHGGAAGsREGWSLLEEVLEQQRLLQLQ |
| P57059 | T460 | Sugiyama | SIK1 SIK SNF1LK | LDTAISEEARQGPGLEEEQDtQEsLPSSTGRRHtLAEVSTR |
| P57059 | T580 | Sugiyama | SIK1 SIK SNF1LK | GAVLLPVSFQEGRRAsDtSLtQGLKAFRQQLRKTTRTKGFL |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60891 | S10 | Sugiyama | PRPS1 | ___________MPNIKIFsGssHQDLSQKIADRLGLELGKV |
| P60891 | S11 | Sugiyama | PRPS1 | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61163 | T248 | Sugiyama | ACTR1A CTRN1 | PQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDLI |
| P61247 | S203 | Sugiyama | RPS3A FTE1 MFTL | EVVNKLIPDsIGKDIEKACQsIyPLHDVFVRKVKMLKKPKF |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61326 | S106 | Sugiyama | MAGOH MAGOHA | QELEIVIGDEHISFTTSKIGsLIDVNQSKDPEGLRVFYYLV |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62081 | T121 | Sugiyama | RPS7 | LPKPTRKSRTKNKQKRPRsRtLtAVHDAILEDLVFPsEIVG |
| P62081 | T123 | Sugiyama | RPS7 | KPTRKSRTKNKQKRPRsRtLtAVHDAILEDLVFPsEIVGKR |
| P62241 | S115 | Sugiyama | RPS8 OK/SW-cl.83 | TLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62826 | S135 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IPIVLCGNKVDIKDRKVKAKsIVFHRKKNLQyyDIsAKSNy |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P78371 | S150 | Sugiyama | CCT2 99D8.1 CCTB | WREATKAAREALLssAVDHGsDEVKFRQDLMNIAGTTLssK |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09666 | S220 | Sugiyama | AHNAK PM227 | QsGKtVIRLPsGsGAAsPtGsAVDIRAGAIsAsGPELQGAG |
| Q10471 | S536 | Sugiyama | GALNT2 | NDSRQKWEQIEGNSKLRHVGsNLCLDSRTAKSGGLSVEVCG |
| Q12849 | S202 | Sugiyama | GRSF1 | IHFLLNRDGKRRGDALIEMEsEQDVQKALEKHRMYMGQRYV |
| Q13098 | S483 | Sugiyama | GPS1 COPS1 CSN1 | QIHVKsPPREGsQGELtPANsQsRMstNM____________ |
| Q13136 | S668 | Sugiyama | PPFIA1 LIP1 | EEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPAss |
| Q13136 | S763 | Sugiyama | PPFIA1 LIP1 | PssPRALRLDRLHKGALHtVsHEDIRDIRNstGsQDGPVSN |
| Q13243 | S153 | Sugiyama | SRSF5 HRS SFRS5 SRP40 | EVTFADAHRPKLNEGVVEFAsYGDLKNAIEKLSGKEINGRK |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13501 | S266 | Sugiyama | SQSTM1 ORCA OSIL | AALsPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQP |
| Q13501 | T269 | Sugiyama | SQSTM1 ORCA OSIL | sPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssC |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q14151 | S827 | Sugiyama | SAFB2 KIAA0138 | HGGPPERHGRDsRDGWGGyGsDKRLsEGRGLPPPPRGGRDW |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14204 | S3257 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | NDKLKKMVKDQQEAEKKKVMsQEIQEQLHKQQEVIADKQMS |
| Q14204 | S4162 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GRIFVFEPPPGVKANMLRTFssIPVSRICKSPNERARLYFL |
| Q14258 | S340 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | KPVYIPEVELNHKLIKGIHQstIDLKNELKQCIGRLQEPTP |
| Q14258 | T341 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | PVYIPEVELNHKLIKGIHQstIDLKNELKQCIGRLQEPTPS |
| Q14432 | S273 | Sugiyama | PDE3A | RYVEQILPQSAEAAPREHLGsQLIAGTKEDIPVFKRRRRss |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14498 | S97 | Sugiyama | RBM39 HCC1 RNPC2 | KERRRSRSRSRDRRFRGRyRsPysGPKFNSAIRGKIGLPHs |
| Q14566 | S568 | Sugiyama | MCM6 | IARRIVDLHSRIEESIDRVYsLDDIRRyLLFARQFKPKISK |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q14C86 | S900 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | TPAEMEAFKQRHSYPERLVRsRssDIVSSVRRPMSDPSWNR |
| Q14C86 | S902 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | AEMEAFKQRHSYPERLVRsRssDIVSSVRRPMSDPSWNRRP |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15021 | S1310 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | RACHTRGLDGIKELEIGQAGsQRAPsAKKPSTGSRyQPLAs |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15424 | S803 | Sugiyama | SAFB HAP HET SAFB1 | RHGGPERHGRDsRDGWGGyGsDKRMsEGRGLPPPPRRDWGD |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15751 | S1514 | Sugiyama | HERC1 | AESRLVHtsPNYRLIKsRsEsDLsQPEsDEEGYALsGRRNV |
| Q15751 | S3238 | Sugiyama | HERC1 | IRTLVRLMCLAAAGRAGLSTsPsAMAsTSERSRGGHSKANK |
| Q15751 | S3240 | Sugiyama | HERC1 | TLVRLMCLAAAGRAGLSTsPsAMAsTSERSRGGHSKANKPI |
| Q15751 | S3244 | Sugiyama | HERC1 | LMCLAAAGRAGLSTsPsAMAsTSERSRGGHSKANKPISCLA |
| Q15785 | S160 | Sugiyama | TOMM34 URCC3 | WRLKLPSIPLVPVsAQKRWNsLPSENHKEMAKSKSKETTAT |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16658 | S234 | Sugiyama | FSCN1 FAN1 HSN SNL | LEFRsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELF |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3KQU3 | S366 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | GPQPDRTHPSAAVPVCPRsAsAsPLtPCSVTRSVHRCAPAG |
| Q3MII6 | S506 | Sugiyama | TBC1D25 OATL1 | DHLATASQGPGGGGRLLRQAsLDGLQQLRDNMGSRRDPLVQ |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q53EL6 | S46 | Sugiyama | PDCD4 H731 | GDEENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKN |
| Q53ET0 | S171 | GPS6|SIGNOR|iPTMNet | CRTC2 TORC2 | NFPAEKGQLFRLPSALNRtssDsALHtsVMNPsPQDtYPGP |
| Q53ET0 | S348 | SIGNOR|iPTMNet | CRTC2 TORC2 | GYDAPGLHSPLSHPSLQSSLsNPNLQASLSSPQPQLQGSHS |
| Q53ET0 | S70 | SIGNOR|iPTMNet | CRTC2 TORC2 | TRLQAQKLRLAYTRssHyGGsLPNVNQIGsGLAEFQsPLHs |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5HYK3 | S165 | Sugiyama | COQ5 | NLSWEEIAKEYQNEEDSLGGsRVVVCDINKEMLKVGKQKAL |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5VWQ8 | S747 | Sugiyama | DAB2IP AF9Q34 AIP1 KIAA1743 | ssysEANEPDLQMANGGKsLsMVDLQDARTLDGEAGsPAGP |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6FI81 | S305 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CAsCPyLGMPAFKPGEKVLLsDsNLHDA_____________ |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q6UUV7 | S162 | SIGNOR | CRTC3 TORC3 | PWKDEKHPGFRLTSALNRtNsDSALHtsALsTKPQDPYGGG |
| Q6UUV9 | S151 | GPS6 | CRTC1 KIAA0616 MECT1 TORC1 WAMTP1 | CPYGTMYLsPPADTSWRRtNsDsALHQstMtPtQPEsFssG |
| Q6UUV9 | S167 | SIGNOR | CRTC1 KIAA0616 MECT1 TORC1 WAMTP1 | RRtNsDsALHQstMtPtQPEsFssGsQDVHQKRVLLLTVPG |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z2W4 | S492 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | VQATGRIADDADPRVALVNDsLsDVtsTtssRVDDHDSEEI |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q7Z5L9 | S360 | Sugiyama | IRF2BP2 | EANGANGSKAVARTARKRKPsPEPEGEVGPPKINGEAQPWL |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86VQ1 | S226 | Sugiyama | GLCCI1 | sCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQRSKQ |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NEY1 | S312 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | TCYDsDDANPRsVssLsNRssPLSWRYGQSSPRLQAGDAPS |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8TB72 | S943 | Sugiyama | PUM2 KIAA0235 PUMH2 | NYVIQHVLEHGRPEDKSKIVsEIRGKVLALSQHKFASNVVE |
| Q8WUF5 | S102 | Sugiyama | PPP1R13L IASPP NKIP1 PPP1R13BL RAI | RGsPRKAATDGADtPFGRsEsAPtLHPysPLsPKGRPssPR |
| Q8WWH5 | S268 | Sugiyama | TRUB1 PUS4 | ECGGGFYIRSLVSDIGKELSsCANVLELTRTKQGPFTLEEH |
| Q8WXH0 | S2781 | Sugiyama | SYNE2 KIAA1011 NUA | ILSQIRKCKVTHDGILARQQsVEsLAEEVKDKVPSLTTYEG |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q96A72 | S108 | Sugiyama | MAGOHB MAGOH2 | QELEIVIGDEHISFTTSKIGsLIDVNQSKDPEGLRVFYYLV |
| Q96EP5 | S208 | Sugiyama | DAZAP1 | AEPRDsKsQAPGQPGAsQWGsRVVPNAANGWAGQPPPTWQQ |
| Q96ES7 | S29 | Sugiyama | SGF29 CCDC101 | RIAELLTELHQLIKQTQEERsRsEHNLVNIQKTHERMQTEN |
| Q96ES7 | S31 | Sugiyama | SGF29 CCDC101 | AELLTELHQLIKQTQEERsRsEHNLVNIQKTHERMQTENKI |
| Q96EY7 | S651 | Sugiyama | PTCD3 MRPS39 TRG15 | VELASAFSLPICEGLTQRVMsDFAINQEQKEALsNLtALts |
| Q96FC9 | S277 | Sugiyama | DDX11 CHL1 CHLR1 KRG2 | LVSLGSRQNLCVNEDVKSLGsVQLINDRCVDMQRSRHEKKK |
| Q96GM8 | S420 | Sugiyama | TOE1 | KNDLEMGIKAARPEIADRATsEVPGsQAsPNPVPGDGLHRA |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q96PK6 | S523 | Sugiyama | RBM14 SIP | AYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASYRGQ |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BS40 | S41 | Sugiyama | LXN | INyQQGTPHRVFEVQKVKQAsMEDIPGRGHKYHLKFAVEEI |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BZ72 | S644 | Sugiyama | PITPNM2 KIAA1457 NIR3 | SGGGGSSGGSSLESSRHLsRsNVDIPRSNGTEDPKRQLPRK |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H0H5 | S257 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | ETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTETDsVGt |
| Q9H1K0 | S548 | Sugiyama | RBSN ZFYVE20 | RELEREREQFRVASLHTRTRsLDFREIGPFQLEPSREPRTH |
| Q9H694 | S803 | Sugiyama | BICC1 | YKPTMTTTYEGSsMsLsRsNsREHLGGGSESDNWRDRNGIG |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9HAU0 | S410 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | NRPNTGPLytEADRVIQRtNsMQQLEQWIKIQKGRGHEEET |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9NQP4 | S125 | Sugiyama | PFDN4 PFD4 | VEsIQRVLADLKVQLYAKFGsNINLEADEs___________ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NVR5 | S773 | Sugiyama | DNAAF2 C14orf104 KTU | EFIKEKSATCSNEEKDNLNEsVITEEKETDGDHLsSLLNKT |
| Q9NVX2 | S331 | Sugiyama | NLE1 HUSSY-07 | ASVNPQDLQGSLQELKERALsRYNLVRGQGPERLVSGSDDF |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NWS0 | S173 | Sugiyama | PIH1D1 NOP17 | KYNLQLNPEWRMMKNRPFMGsIsQQNIRSEQRPRIQELGDL |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9NZM1 | S727 | Sugiyama | MYOF FER1L3 KIAA1207 | PLTEGKANVTVLDTQIRKLRsRsLsQIHEAAVRMRSEATDV |
| Q9P1Y5 | S431 | Sugiyama | CAMSAP3 KIAA1543 | FGLDSDVDVVMGDPVLLRsVssDsLGPPRPAPARTPtQPPP |
| Q9P265 | S203 | Sugiyama | DIP2B KIAA1463 | stsssASSTLSHGEVKGtsGsLADVFANtRIENFSAPPDVT |
| Q9UBC2 | S672 | Sugiyama | EPS15L1 EPS15R | ttstDPFGGDPFKESDPFRGsAtDDFFKKQTKNDPFTSDPF |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | T329 | Sugiyama | NDRG3 | FLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVts |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UIQ6 | S51 | Sugiyama | LNPEP OTASE | AKEPCLHPLEPDEVEyEPRGsRLLVRGLGEHEMEEDEEDyE |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9UNZ2 | S74 | Sugiyama | NSFL1C UBXN2C | SQATPssVsRGTAPSDNRVtsFRDLIHDQDEDEEEEEGQRF |
| Q9UPQ0 | S207 | Sugiyama | LIMCH1 KIAA1102 | RsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRGssD |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2398 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ANLtsPRVPLsAyERVsGRtsPPLLDRARsRtPPsAPsQsR |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ80 | S335 | Sugiyama | PA2G4 EBP1 | FVAQFKFTVLLMPNGPMRITsGPFEPDLyKsEMEVQDAELK |
| Q9UQL6 | S259 | GPS6 | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | GPS6 | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y2B0 | S178 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NVKDKLCSKRtDLCDHALHIsHDEL________________ |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2U5 | S239 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | SLDSPLDGESYPKSRMPRAQsyPDNHQEFSDyDNPIFEKFG |
| Q9Y2V2 | S52 | Sugiyama | CARHSP1 | sPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCKCFCR |
| Q9Y490 | S1535 | Sugiyama | TLN1 KIAA1027 TLN | RTTNPTAKRQFVQSAKEVANsTANLVKTIKALDGAFTEENR |
| Q9Y4G6 | S1537 | Sugiyama | TLN2 KIAA0320 | KTANPVAKRHFVQSAKEVANsTANLVKTIKALDGDFSEDNR |
| Q9Y4W2 | S636 | Sugiyama | LAS1L MSTP060 | EsPtAENARLLAQKRGALQGsAWQVssEDVRWDTFPLGRMP |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y5S2 | S470 | Sugiyama | CDC42BPB KIAA1124 | LEQEKLELSRKLQESTQTVQsLHGsSRALSNsNRDKEIKKL |
| Q9Y5S2 | S474 | Sugiyama | CDC42BPB KIAA1124 | KLELSRKLQESTQTVQsLHGsSRALSNsNRDKEIKKLNEEI |
| Q9Y618 | T1383 | PSP | NCOR2 CTG26 | YVEAQEDYLRREAKLLKREGtPPPPPPSRDLTEAYKTQALG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 1.455246e-08 | 7.837 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.582664e-06 | 5.801 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.433335e-05 | 4.844 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.912853e-05 | 4.718 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.831008e-05 | 4.737 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.170919e-05 | 4.499 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.810238e-05 | 4.419 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.028285e-05 | 4.395 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.266227e-05 | 4.033 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.082411e-04 | 3.966 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.253888e-04 | 3.647 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.528032e-04 | 3.597 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.454604e-04 | 3.462 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.765696e-04 | 3.424 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.098170e-04 | 3.387 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.174089e-04 | 3.379 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.202408e-04 | 3.284 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.547779e-04 | 3.256 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.404816e-04 | 3.193 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.497924e-04 | 3.187 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.114763e-04 | 3.148 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.621181e-04 | 3.118 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.083866e-03 | 2.965 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.076684e-03 | 2.968 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.232647e-03 | 2.909 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.283001e-03 | 2.892 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.299706e-03 | 2.886 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.257589e-03 | 2.900 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.398253e-03 | 2.854 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.599831e-03 | 2.796 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.574310e-03 | 2.803 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.754882e-03 | 2.756 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.719901e-03 | 2.764 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.848243e-03 | 2.733 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.367146e-03 | 2.626 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.785488e-03 | 2.555 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.862181e-03 | 2.543 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.236685e-03 | 2.490 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.236685e-03 | 2.490 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.263896e-03 | 2.486 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.236685e-03 | 2.490 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.463165e-03 | 2.461 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.463165e-03 | 2.461 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.487829e-03 | 2.457 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.817696e-03 | 2.418 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.921589e-03 | 2.407 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.096160e-03 | 2.388 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.164069e-03 | 2.380 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.367918e-03 | 2.360 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.535502e-03 | 2.343 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.611874e-03 | 2.336 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.693738e-03 | 2.328 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.705399e-03 | 2.327 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.783121e-03 | 2.238 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.530724e-03 | 2.257 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.544843e-03 | 2.256 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.693346e-03 | 2.245 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.530724e-03 | 2.257 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.530724e-03 | 2.257 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.402833e-03 | 2.267 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.544843e-03 | 2.256 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.530724e-03 | 2.257 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.150982e-03 | 2.288 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.219502e-03 | 2.282 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.530724e-03 | 2.257 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.957608e-03 | 2.225 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.057095e-03 | 2.218 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.359539e-03 | 2.197 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.359539e-03 | 2.197 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.484257e-03 | 2.188 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 7.132821e-03 | 2.147 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.841147e-03 | 2.165 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.813698e-03 | 2.167 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.565451e-03 | 2.121 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 8.179501e-03 | 2.087 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.201088e-03 | 2.086 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.189203e-03 | 2.087 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.201088e-03 | 2.086 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.409697e-03 | 2.075 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.686027e-03 | 2.014 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.686027e-03 | 2.014 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.717262e-03 | 2.012 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.012731e-02 | 1.995 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.019081e-02 | 1.992 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.042829e-02 | 1.982 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.223974e-02 | 1.912 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.212666e-02 | 1.916 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.179410e-02 | 1.928 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.179410e-02 | 1.928 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.217043e-02 | 1.915 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.572821e-02 | 1.803 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.572821e-02 | 1.803 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.572821e-02 | 1.803 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.572821e-02 | 1.803 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.572821e-02 | 1.803 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.572821e-02 | 1.803 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.572821e-02 | 1.803 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.572821e-02 | 1.803 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.572821e-02 | 1.803 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.572821e-02 | 1.803 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.572821e-02 | 1.803 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.445804e-02 | 1.840 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.445804e-02 | 1.840 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.475341e-02 | 1.831 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.474813e-02 | 1.831 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.441301e-02 | 1.841 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.441301e-02 | 1.841 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.475341e-02 | 1.831 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.340233e-02 | 1.873 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.514041e-02 | 1.820 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.647573e-02 | 1.783 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.441301e-02 | 1.841 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.456958e-02 | 1.837 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.394524e-02 | 1.856 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.477899e-02 | 1.830 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.662099e-02 | 1.779 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.700996e-02 | 1.769 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.770559e-02 | 1.752 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.791696e-02 | 1.747 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.762094e-02 | 1.754 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.864949e-02 | 1.729 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.834307e-02 | 1.737 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.770559e-02 | 1.752 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.811202e-02 | 1.742 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.770559e-02 | 1.752 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.889251e-02 | 1.724 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.915344e-02 | 1.718 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.915344e-02 | 1.718 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.931236e-02 | 1.714 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.949653e-02 | 1.710 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.140414e-02 | 1.670 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.141296e-02 | 1.669 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.143787e-02 | 1.669 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.177463e-02 | 1.662 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.225253e-02 | 1.653 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.479340e-02 | 1.606 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.479340e-02 | 1.606 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.322854e-02 | 1.634 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.551287e-02 | 1.593 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.623168e-02 | 1.581 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.737783e-02 | 1.563 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.820758e-02 | 1.550 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.820758e-02 | 1.550 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.820758e-02 | 1.550 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.820758e-02 | 1.550 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.820758e-02 | 1.550 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.820758e-02 | 1.550 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.820758e-02 | 1.550 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.216564e-02 | 1.493 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.160340e-02 | 1.500 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.096143e-02 | 1.509 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.260128e-02 | 1.487 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.216564e-02 | 1.493 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.318052e-02 | 1.479 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.330336e-02 | 1.478 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.330336e-02 | 1.478 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.330336e-02 | 1.478 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.341812e-02 | 1.476 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.369167e-02 | 1.472 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.694275e-02 | 1.432 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.713516e-02 | 1.430 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.713516e-02 | 1.430 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.893506e-02 | 1.410 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.136244e-02 | 1.383 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.893506e-02 | 1.410 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.839595e-02 | 1.416 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.876485e-02 | 1.412 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.037165e-02 | 1.394 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.916155e-02 | 1.407 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.235261e-02 | 1.373 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.272828e-02 | 1.369 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.291026e-02 | 1.367 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.291026e-02 | 1.367 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.291026e-02 | 1.367 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.400319e-02 | 1.357 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.400319e-02 | 1.357 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.402037e-02 | 1.356 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.402037e-02 | 1.356 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.402037e-02 | 1.356 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.402037e-02 | 1.356 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.418510e-02 | 1.355 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.418510e-02 | 1.355 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.734782e-02 | 1.325 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.657409e-02 | 1.332 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.657409e-02 | 1.332 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.657409e-02 | 1.332 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.657409e-02 | 1.332 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.777436e-02 | 1.321 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.681878e-02 | 1.330 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.014011e-02 | 1.300 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.623239e-02 | 1.335 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.141555e-02 | 1.289 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.155838e-02 | 1.288 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.253504e-02 | 1.280 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.411111e-02 | 1.267 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.510866e-02 | 1.259 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.627952e-02 | 1.250 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.627952e-02 | 1.250 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.642018e-02 | 1.249 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.682281e-02 | 1.245 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.682281e-02 | 1.245 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 5.836559e-02 | 1.234 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 5.836559e-02 | 1.234 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.372342e-02 | 1.196 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.906580e-02 | 1.229 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.363513e-02 | 1.196 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.268704e-02 | 1.203 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.492138e-02 | 1.188 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.247202e-02 | 1.204 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.831563e-02 | 1.234 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.249025e-02 | 1.204 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.372342e-02 | 1.196 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.968010e-02 | 1.224 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.968010e-02 | 1.224 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.406362e-02 | 1.193 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.356508e-02 | 1.197 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.372342e-02 | 1.196 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.525379e-02 | 1.185 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.612606e-02 | 1.180 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.724990e-02 | 1.172 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.838007e-02 | 1.165 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.838007e-02 | 1.165 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.856331e-02 | 1.164 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.856331e-02 | 1.164 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.871526e-02 | 1.163 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.904394e-02 | 1.161 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.904394e-02 | 1.161 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.904394e-02 | 1.161 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.230040e-02 | 1.141 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.230040e-02 | 1.141 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.230040e-02 | 1.141 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.129086e-02 | 1.090 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.129086e-02 | 1.090 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.129086e-02 | 1.090 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.129086e-02 | 1.090 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.081971e-02 | 1.150 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.980696e-02 | 1.098 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.774760e-02 | 1.109 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.230040e-02 | 1.141 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.261787e-02 | 1.139 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.762441e-02 | 1.110 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.187186e-02 | 1.143 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.141185e-02 | 1.146 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.081971e-02 | 1.150 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.228878e-02 | 1.141 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.129086e-02 | 1.090 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.025377e-02 | 1.096 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.271052e-02 | 1.138 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.230040e-02 | 1.141 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.105433e-02 | 1.148 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.230040e-02 | 1.141 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.230040e-02 | 1.141 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.774760e-02 | 1.109 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 8.677422e-02 | 1.062 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 8.677422e-02 | 1.062 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 8.677422e-02 | 1.062 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.681609e-02 | 1.061 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.699224e-02 | 1.061 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.699224e-02 | 1.061 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.770017e-02 | 1.057 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.863687e-02 | 1.052 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 9.037972e-02 | 1.044 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.037972e-02 | 1.044 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 9.037972e-02 | 1.044 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.135030e-02 | 1.039 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.466735e-02 | 1.024 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.466735e-02 | 1.024 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.483915e-02 | 1.023 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.506965e-02 | 1.022 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.551335e-02 | 1.020 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 9.551335e-02 | 1.020 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 9.551335e-02 | 1.020 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.213413e-01 | 0.916 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.213413e-01 | 0.916 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 2.279652e-01 | 0.642 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.279652e-01 | 0.642 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.279652e-01 | 0.642 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.279652e-01 | 0.642 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.127926e-01 | 0.948 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.826389e-01 | 0.738 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.826389e-01 | 0.738 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.216558e-01 | 0.493 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.216558e-01 | 0.493 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.216558e-01 | 0.493 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.216558e-01 | 0.493 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.216558e-01 | 0.493 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.216558e-01 | 0.493 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.216558e-01 | 0.493 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.216558e-01 | 0.493 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.216558e-01 | 0.493 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.216558e-01 | 0.493 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.216558e-01 | 0.493 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.216558e-01 | 0.493 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.216558e-01 | 0.493 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.216558e-01 | 0.493 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.216558e-01 | 0.493 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.216558e-01 | 0.493 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.216558e-01 | 0.493 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.216558e-01 | 0.493 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.216558e-01 | 0.493 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.413539e-01 | 0.850 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.413539e-01 | 0.850 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.413539e-01 | 0.850 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.295172e-01 | 0.639 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.295172e-01 | 0.639 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.295172e-01 | 0.639 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.295172e-01 | 0.639 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.295172e-01 | 0.639 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.720156e-01 | 0.764 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 1.720156e-01 | 0.764 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 1.720156e-01 | 0.764 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.720156e-01 | 0.764 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.321852e-01 | 0.879 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.031296e-01 | 0.987 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.206346e-01 | 0.919 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.555770e-01 | 0.808 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.043379e-01 | 0.690 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.043379e-01 | 0.690 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.043379e-01 | 0.690 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.043379e-01 | 0.690 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.043379e-01 | 0.690 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.043379e-01 | 0.690 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.770580e-01 | 0.557 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.770580e-01 | 0.557 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.770580e-01 | 0.557 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.770580e-01 | 0.557 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.770580e-01 | 0.557 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.770580e-01 | 0.557 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.039814e-01 | 0.394 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.039814e-01 | 0.394 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.039814e-01 | 0.394 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.039814e-01 | 0.394 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.039814e-01 | 0.394 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.246868e-01 | 0.904 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.378970e-01 | 0.624 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.115175e-01 | 0.953 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.115175e-01 | 0.953 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.982380e-02 | 1.001 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.063716e-01 | 0.685 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.063716e-01 | 0.685 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.244108e-01 | 0.489 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.244108e-01 | 0.489 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.244108e-01 | 0.489 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.244108e-01 | 0.489 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.804582e-01 | 0.744 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.804582e-01 | 0.744 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.587475e-01 | 0.799 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.722954e-01 | 0.565 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.333619e-01 | 0.632 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.333619e-01 | 0.632 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.333619e-01 | 0.632 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.024777e-01 | 0.694 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.519339e-01 | 0.818 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.519339e-01 | 0.818 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.722708e-01 | 0.764 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.722708e-01 | 0.764 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.963462e-01 | 0.707 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.963462e-01 | 0.707 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.253376e-01 | 0.647 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.253376e-01 | 0.647 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.611378e-01 | 0.583 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.611378e-01 | 0.583 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.611378e-01 | 0.583 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.071677e-01 | 0.513 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.071677e-01 | 0.513 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.071677e-01 | 0.513 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.709216e-01 | 0.431 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.709216e-01 | 0.431 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.709216e-01 | 0.431 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.709216e-01 | 0.431 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.709216e-01 | 0.431 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.709216e-01 | 0.431 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.709216e-01 | 0.431 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.763199e-01 | 0.322 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.763199e-01 | 0.322 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.763199e-01 | 0.322 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.763199e-01 | 0.322 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.763199e-01 | 0.322 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.763199e-01 | 0.322 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 4.763199e-01 | 0.322 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.763199e-01 | 0.322 | 0 | 0 |
| Defective CYP7B1 causes SPG5A and CBAS3 | R-HSA-5579013 | 4.763199e-01 | 0.322 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.763199e-01 | 0.322 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.763199e-01 | 0.322 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.037832e-01 | 0.984 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.473775e-01 | 0.832 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.473775e-01 | 0.832 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.666841e-01 | 0.778 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.893419e-01 | 0.723 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.893419e-01 | 0.723 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.893419e-01 | 0.723 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.893419e-01 | 0.723 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.893419e-01 | 0.723 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.608002e-01 | 0.794 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.608002e-01 | 0.794 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.608002e-01 | 0.794 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.608002e-01 | 0.794 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.820600e-01 | 0.740 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.894969e-01 | 0.538 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.070647e-01 | 0.684 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.070647e-01 | 0.684 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.747852e-01 | 0.757 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.368729e-01 | 0.625 | 1 | 1 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.421848e-01 | 0.466 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.421848e-01 | 0.466 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.421848e-01 | 0.466 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.421848e-01 | 0.466 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.421848e-01 | 0.466 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.421848e-01 | 0.466 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.421848e-01 | 0.466 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.421848e-01 | 0.466 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.101736e-01 | 0.958 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.580252e-01 | 0.588 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.182452e-01 | 0.497 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.182452e-01 | 0.497 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.182452e-01 | 0.497 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.182452e-01 | 0.497 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.182452e-01 | 0.497 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.160975e-01 | 0.381 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.160975e-01 | 0.381 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.160975e-01 | 0.381 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.442306e-01 | 0.612 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.976977e-01 | 0.526 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.770546e-01 | 0.424 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.770546e-01 | 0.424 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.016720e-01 | 0.520 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.922291e-01 | 0.716 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.960267e-01 | 0.708 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.687537e-01 | 0.571 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.687537e-01 | 0.571 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.033395e-01 | 0.518 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.033395e-01 | 0.518 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.115229e-01 | 0.386 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.595777e-01 | 0.338 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.595777e-01 | 0.338 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.595777e-01 | 0.338 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.398825e-01 | 0.268 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.398825e-01 | 0.268 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.398825e-01 | 0.268 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.398825e-01 | 0.268 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.398825e-01 | 0.268 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.398825e-01 | 0.268 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.398825e-01 | 0.268 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.398825e-01 | 0.268 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.549933e-01 | 0.593 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.549933e-01 | 0.593 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 3.731182e-01 | 0.428 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.224096e-01 | 0.492 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.691951e-01 | 0.433 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.453717e-01 | 0.351 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.772944e-01 | 0.557 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.336506e-01 | 0.363 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.336506e-01 | 0.363 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.336506e-01 | 0.363 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.011085e-01 | 0.300 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.517667e-01 | 0.454 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.235605e-01 | 0.373 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.235605e-01 | 0.373 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.797757e-01 | 0.420 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.204368e-01 | 0.657 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.146117e-01 | 0.382 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.065112e-01 | 0.391 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.065112e-01 | 0.391 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.618544e-01 | 0.335 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.618544e-01 | 0.335 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.490467e-01 | 0.457 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.856940e-01 | 0.414 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.485253e-01 | 0.348 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.485253e-01 | 0.348 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.485253e-01 | 0.348 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.485253e-01 | 0.348 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.372106e-01 | 0.359 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.892228e-01 | 0.410 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.100354e-01 | 0.509 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.479639e-01 | 0.349 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.479639e-01 | 0.349 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.479639e-01 | 0.349 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.895501e-01 | 0.310 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.895501e-01 | 0.310 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.105106e-01 | 0.292 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.105106e-01 | 0.292 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.405226e-01 | 0.267 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.405226e-01 | 0.267 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.405226e-01 | 0.267 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.405226e-01 | 0.267 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.405226e-01 | 0.267 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.405226e-01 | 0.267 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.405226e-01 | 0.267 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.405226e-01 | 0.267 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.463714e-01 | 0.350 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.818487e-01 | 0.317 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.818487e-01 | 0.317 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.888546e-01 | 0.311 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.415290e-01 | 0.266 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.134555e-01 | 0.289 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.134555e-01 | 0.289 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.430360e-01 | 0.265 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.430360e-01 | 0.265 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.777222e-01 | 0.238 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.777222e-01 | 0.238 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.777222e-01 | 0.238 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.777222e-01 | 0.238 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.288041e-01 | 0.277 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.319118e-01 | 0.274 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 5.713792e-01 | 0.243 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.686704e-01 | 0.245 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.674877e-01 | 0.246 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.686928e-01 | 0.245 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.767192e-01 | 0.239 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.138291e-01 | 0.670 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.345422e-01 | 0.871 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.088560e-01 | 0.963 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.218876e-01 | 0.914 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.075657e-01 | 0.683 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.024777e-01 | 0.694 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.636769e-01 | 0.579 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.982380e-02 | 1.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.781054e-01 | 0.749 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.333619e-01 | 0.632 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.050521e-01 | 0.392 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.620515e-01 | 0.582 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.722708e-01 | 0.764 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.770546e-01 | 0.424 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.011085e-01 | 0.300 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.037658e-01 | 0.298 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.230074e-01 | 0.910 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.796542e-01 | 0.553 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.549933e-01 | 0.593 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.526184e-01 | 0.344 | 1 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.206346e-01 | 0.919 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.867731e-01 | 0.729 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.075657e-01 | 0.683 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.075657e-01 | 0.683 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.777118e-01 | 0.750 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.767192e-01 | 0.239 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.378443e-01 | 0.861 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.105106e-01 | 0.292 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.327499e-01 | 0.273 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.463714e-01 | 0.350 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.075657e-01 | 0.683 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.421848e-01 | 0.466 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.022972e-01 | 0.990 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.617085e-01 | 0.791 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.832745e-01 | 0.548 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.595777e-01 | 0.338 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.894969e-01 | 0.538 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.282047e-01 | 0.368 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.777222e-01 | 0.238 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.627127e-01 | 0.581 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.235605e-01 | 0.373 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.998925e-01 | 0.301 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.795976e-01 | 0.421 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.165701e-01 | 0.664 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.076894e-01 | 0.512 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.770546e-01 | 0.424 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.357465e-01 | 0.628 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.986322e-01 | 0.302 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.617085e-01 | 0.791 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.378970e-01 | 0.624 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.071677e-01 | 0.513 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.160975e-01 | 0.381 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.453717e-01 | 0.351 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.382633e-01 | 0.471 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.011085e-01 | 0.300 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.518508e-01 | 0.258 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.054618e-01 | 0.687 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.282047e-01 | 0.368 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.357465e-01 | 0.628 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.107028e-01 | 0.508 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.198237e-01 | 0.921 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.894969e-01 | 0.538 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.471991e-01 | 0.459 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.054032e-01 | 0.296 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.378970e-01 | 0.624 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.378970e-01 | 0.624 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.709216e-01 | 0.431 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.182452e-01 | 0.497 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.976977e-01 | 0.526 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.635499e-01 | 0.579 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.668727e-01 | 0.574 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.115229e-01 | 0.386 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.595777e-01 | 0.338 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.549933e-01 | 0.593 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.983933e-01 | 0.400 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.123447e-01 | 0.673 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.162846e-01 | 0.665 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.104092e-01 | 0.957 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.477346e-01 | 0.831 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.975087e-01 | 0.303 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.687537e-01 | 0.571 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.826389e-01 | 0.738 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.295172e-01 | 0.639 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.720156e-01 | 0.764 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.321852e-01 | 0.879 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.244108e-01 | 0.489 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.117655e-01 | 0.952 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.071677e-01 | 0.513 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.421848e-01 | 0.466 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.421848e-01 | 0.466 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.947376e-01 | 0.711 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.080066e-01 | 0.967 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.115229e-01 | 0.386 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.465269e-01 | 0.460 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.235605e-01 | 0.373 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.274747e-01 | 0.369 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.854798e-01 | 0.314 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.988250e-01 | 0.399 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.509654e-01 | 0.600 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.509654e-01 | 0.600 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.893044e-01 | 0.723 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.733154e-01 | 0.761 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.378443e-01 | 0.861 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.699673e-01 | 0.770 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.972229e-01 | 0.705 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.357465e-01 | 0.628 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.919156e-01 | 0.407 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.368980e-01 | 0.360 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.345422e-01 | 0.871 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.983933e-01 | 0.400 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.288041e-01 | 0.277 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.057049e-01 | 0.687 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.555770e-01 | 0.808 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.225803e-01 | 0.912 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.813701e-01 | 0.741 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.447462e-01 | 0.264 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.713792e-01 | 0.243 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.695220e-01 | 0.244 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.888546e-01 | 0.311 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.605344e-01 | 0.443 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.605344e-01 | 0.443 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.065112e-01 | 0.391 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.345422e-01 | 0.871 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.019273e-01 | 0.695 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.376355e-01 | 0.359 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.033395e-01 | 0.518 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.691951e-01 | 0.433 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.583015e-01 | 0.801 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.695220e-01 | 0.244 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.918349e-01 | 0.535 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.199546e-01 | 0.495 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.039814e-01 | 0.394 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.803739e-01 | 0.744 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.402964e-01 | 0.853 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.378443e-01 | 0.861 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.088560e-01 | 0.963 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.709216e-01 | 0.431 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.709216e-01 | 0.431 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 3.770546e-01 | 0.424 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.635499e-01 | 0.579 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.838605e-01 | 0.547 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.205513e-01 | 0.494 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.336506e-01 | 0.363 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.372106e-01 | 0.359 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.027530e-01 | 0.395 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.405226e-01 | 0.267 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.794694e-01 | 0.554 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.643343e-01 | 0.333 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.777222e-01 | 0.238 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.777222e-01 | 0.238 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.224096e-01 | 0.492 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.596442e-01 | 0.338 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.339692e-01 | 0.363 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.171755e-01 | 0.931 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.133471e-01 | 0.946 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.701499e-01 | 0.244 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.746868e-01 | 0.758 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.710963e-01 | 0.767 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.894969e-01 | 0.538 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.635499e-01 | 0.579 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.675587e-01 | 0.246 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.378443e-01 | 0.861 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.713792e-01 | 0.243 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.489430e-01 | 0.827 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.856940e-01 | 0.414 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.856940e-01 | 0.414 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.856940e-01 | 0.414 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.856940e-01 | 0.414 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.732009e-01 | 0.325 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.174328e-01 | 0.663 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.393889e-01 | 0.856 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.059326e-01 | 0.686 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.722278e-01 | 0.326 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.319118e-01 | 0.274 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.237474e-01 | 0.373 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.578389e-01 | 0.802 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.976977e-01 | 0.526 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.598992e-01 | 0.444 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.375121e-01 | 0.862 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.804582e-01 | 0.744 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.722954e-01 | 0.565 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.453717e-01 | 0.351 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.895501e-01 | 0.310 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.126554e-01 | 0.384 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 5.430360e-01 | 0.265 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.218971e-01 | 0.282 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.264061e-01 | 0.370 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.933762e-01 | 0.533 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.152068e-01 | 0.667 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.138726e-01 | 0.944 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.478370e-01 | 0.459 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.213780e-01 | 0.283 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.957913e-01 | 0.708 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.495368e-01 | 0.603 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.844644e-01 | 0.546 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.117143e-01 | 0.291 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.482807e-01 | 0.829 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.321852e-01 | 0.879 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.031296e-01 | 0.987 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.421848e-01 | 0.466 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.850970e-01 | 0.545 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.115229e-01 | 0.386 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.442293e-01 | 0.463 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.983933e-01 | 0.400 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.970923e-01 | 0.527 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.713792e-01 | 0.243 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.484807e-01 | 0.261 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.233546e-01 | 0.651 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.117143e-01 | 0.291 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.608002e-01 | 0.794 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.539211e-01 | 0.343 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.271745e-01 | 0.896 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.054032e-01 | 0.296 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.617085e-01 | 0.791 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.653872e-01 | 0.781 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.509327e-01 | 0.600 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.282047e-01 | 0.368 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.234184e-01 | 0.909 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.431671e-01 | 0.844 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.912608e-01 | 0.309 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.675587e-01 | 0.246 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.954212e-01 | 0.403 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.947376e-01 | 0.711 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.672815e-01 | 0.246 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.991788e-01 | 0.524 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.732009e-01 | 0.325 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.874759e-02 | 1.005 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.061979e-01 | 0.391 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.375121e-01 | 0.862 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.216558e-01 | 0.493 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.413539e-01 | 0.850 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.295172e-01 | 0.639 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.720156e-01 | 0.764 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.043379e-01 | 0.690 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.039814e-01 | 0.394 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.039814e-01 | 0.394 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 2.378970e-01 | 0.624 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.611378e-01 | 0.583 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.611378e-01 | 0.583 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.709216e-01 | 0.431 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.709216e-01 | 0.431 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.709216e-01 | 0.431 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.763199e-01 | 0.322 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.763199e-01 | 0.322 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.763199e-01 | 0.322 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.037832e-01 | 0.984 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.070647e-01 | 0.684 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.160975e-01 | 0.381 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.043270e-01 | 0.690 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.976977e-01 | 0.526 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.796542e-01 | 0.553 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.398825e-01 | 0.268 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.398825e-01 | 0.268 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.398825e-01 | 0.268 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.731182e-01 | 0.428 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.442293e-01 | 0.463 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.549052e-01 | 0.594 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.784179e-01 | 0.320 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.372106e-01 | 0.359 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.105106e-01 | 0.292 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.405226e-01 | 0.267 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 5.430360e-01 | 0.265 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.777222e-01 | 0.238 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.777222e-01 | 0.238 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.777222e-01 | 0.238 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.447462e-01 | 0.264 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.713792e-01 | 0.243 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.008458e-01 | 0.996 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.131518e-01 | 0.504 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.251642e-01 | 0.648 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.251642e-01 | 0.648 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.552911e-01 | 0.593 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.818487e-01 | 0.317 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.869209e-01 | 0.728 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.183025e-01 | 0.927 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.463714e-01 | 0.350 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.975087e-01 | 0.303 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.375570e-01 | 0.862 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.375570e-01 | 0.862 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.674877e-01 | 0.246 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.856940e-01 | 0.414 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 5.166389e-01 | 0.287 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.288041e-01 | 0.277 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.330430e-01 | 0.876 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.959698e-01 | 0.529 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.855843e-01 | 0.731 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.926535e-01 | 0.307 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.370555e-01 | 0.359 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.109989e-01 | 0.955 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.478370e-01 | 0.459 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.982628e-01 | 0.703 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.770546e-01 | 0.424 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.709216e-01 | 0.431 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.453717e-01 | 0.351 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.089686e-01 | 0.293 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.980231e-01 | 0.703 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.676603e-01 | 0.776 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.957720e-01 | 0.403 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.292110e-01 | 0.640 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.431671e-01 | 0.844 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.398825e-01 | 0.268 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.011085e-01 | 0.300 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.732009e-01 | 0.325 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.730742e-01 | 0.564 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.784179e-01 | 0.320 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.713792e-01 | 0.243 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.315831e-01 | 0.479 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.975087e-01 | 0.303 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.721894e-01 | 0.429 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.672815e-01 | 0.246 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.772397e-01 | 0.751 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.555770e-01 | 0.808 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.770580e-01 | 0.557 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.425394e-01 | 0.846 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.094395e-01 | 0.961 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.770546e-01 | 0.424 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.635499e-01 | 0.579 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.398825e-01 | 0.268 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.990708e-01 | 0.399 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.605676e-01 | 0.337 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.897505e-01 | 0.722 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.675587e-01 | 0.246 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.548446e-01 | 0.810 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.198195e-01 | 0.658 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.856940e-01 | 0.414 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.177690e-01 | 0.662 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.341129e-01 | 0.476 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.867669e-01 | 0.542 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.162846e-01 | 0.665 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.244461e-01 | 0.905 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.777222e-01 | 0.238 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.421848e-01 | 0.466 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.415290e-01 | 0.266 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 5.685567e-01 | 0.245 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.378443e-01 | 0.861 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.039814e-01 | 0.394 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.722954e-01 | 0.565 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.378443e-01 | 0.861 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.378443e-01 | 0.861 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.089507e-01 | 0.680 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.490040e-01 | 0.604 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.595777e-01 | 0.338 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.398825e-01 | 0.268 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.336506e-01 | 0.363 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.011085e-01 | 0.300 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.784179e-01 | 0.320 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.732009e-01 | 0.325 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.105106e-01 | 0.292 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.405226e-01 | 0.267 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.643955e-01 | 0.438 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.585765e-01 | 0.587 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.818538e-01 | 0.317 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.473775e-01 | 0.832 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.254874e-01 | 0.901 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.272820e-01 | 0.369 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.720156e-01 | 0.764 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.233157e-01 | 0.909 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.053412e-01 | 0.977 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.866795e-01 | 0.543 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.378970e-01 | 0.624 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.763199e-01 | 0.322 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.471991e-01 | 0.459 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.832745e-01 | 0.548 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.595777e-01 | 0.338 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.405226e-01 | 0.267 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.731182e-01 | 0.428 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.226586e-01 | 0.491 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.453717e-01 | 0.351 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.676603e-01 | 0.776 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.686704e-01 | 0.245 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.096049e-01 | 0.960 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.470182e-01 | 0.833 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.039814e-01 | 0.394 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.709216e-01 | 0.431 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.666841e-01 | 0.778 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.160975e-01 | 0.381 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.398825e-01 | 0.268 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.398825e-01 | 0.268 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.011085e-01 | 0.300 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.065112e-01 | 0.391 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.272820e-01 | 0.369 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.405226e-01 | 0.267 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.461052e-01 | 0.263 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.470182e-01 | 0.833 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.179854e-01 | 0.928 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.312006e-01 | 0.480 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.595777e-01 | 0.338 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.666841e-01 | 0.778 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.376355e-01 | 0.359 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.630706e-01 | 0.440 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.405226e-01 | 0.267 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.770580e-01 | 0.557 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.244108e-01 | 0.489 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.709216e-01 | 0.431 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.421848e-01 | 0.466 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.595777e-01 | 0.338 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.618544e-01 | 0.335 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.536850e-01 | 0.451 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.583015e-01 | 0.801 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.471991e-01 | 0.459 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.336506e-01 | 0.363 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.713792e-01 | 0.243 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.490467e-01 | 0.457 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.963906e-01 | 0.528 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 4.895501e-01 | 0.310 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.713792e-01 | 0.243 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.854178e-01 | 0.233 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.854178e-01 | 0.233 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.855621e-01 | 0.232 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.891981e-01 | 0.230 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.897685e-01 | 0.229 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.902950e-01 | 0.229 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.934837e-01 | 0.227 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.934837e-01 | 0.227 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.934837e-01 | 0.227 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.934837e-01 | 0.227 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.944912e-01 | 0.226 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.957332e-01 | 0.225 | 0 | 0 |
| Defective CYP17A1 causes AH5 | R-HSA-5579028 | 5.957332e-01 | 0.225 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.957332e-01 | 0.225 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.957332e-01 | 0.225 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.957332e-01 | 0.225 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.957332e-01 | 0.225 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 5.957332e-01 | 0.225 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.957332e-01 | 0.225 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.957332e-01 | 0.225 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.957332e-01 | 0.225 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.957332e-01 | 0.225 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.957332e-01 | 0.225 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.957332e-01 | 0.225 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.957332e-01 | 0.225 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.957332e-01 | 0.225 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.999913e-01 | 0.222 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.999913e-01 | 0.222 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.999913e-01 | 0.222 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.999913e-01 | 0.222 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.003852e-01 | 0.222 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.015212e-01 | 0.221 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.025802e-01 | 0.220 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.046372e-01 | 0.219 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.046372e-01 | 0.219 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.073417e-01 | 0.217 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.073417e-01 | 0.217 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.126640e-01 | 0.213 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.126640e-01 | 0.213 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.126640e-01 | 0.213 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.126640e-01 | 0.213 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.126640e-01 | 0.213 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.126640e-01 | 0.213 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.146578e-01 | 0.211 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.158519e-01 | 0.211 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.174294e-01 | 0.209 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.174294e-01 | 0.209 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.174294e-01 | 0.209 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.174294e-01 | 0.209 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.174294e-01 | 0.209 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.174294e-01 | 0.209 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.174294e-01 | 0.209 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.273174e-01 | 0.203 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.273174e-01 | 0.203 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.307262e-01 | 0.200 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.322284e-01 | 0.199 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.344548e-01 | 0.198 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.360807e-01 | 0.196 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.369136e-01 | 0.196 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.369136e-01 | 0.196 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 6.404721e-01 | 0.193 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.404721e-01 | 0.193 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.428489e-01 | 0.192 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.448075e-01 | 0.191 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.448075e-01 | 0.191 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.448075e-01 | 0.191 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.448075e-01 | 0.191 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.448075e-01 | 0.191 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.448075e-01 | 0.191 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.448075e-01 | 0.191 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.448075e-01 | 0.191 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.448075e-01 | 0.191 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.448075e-01 | 0.191 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.448075e-01 | 0.191 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.448075e-01 | 0.191 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.448075e-01 | 0.191 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.448075e-01 | 0.191 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.448075e-01 | 0.191 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.448075e-01 | 0.191 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.448075e-01 | 0.191 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.448075e-01 | 0.191 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.448075e-01 | 0.191 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.452741e-01 | 0.190 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.453481e-01 | 0.190 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.453481e-01 | 0.190 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.453481e-01 | 0.190 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.453481e-01 | 0.190 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 6.453481e-01 | 0.190 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.453481e-01 | 0.190 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.453481e-01 | 0.190 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.453481e-01 | 0.190 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.453481e-01 | 0.190 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.453481e-01 | 0.190 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.453481e-01 | 0.190 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.453481e-01 | 0.190 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.453481e-01 | 0.190 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.476313e-01 | 0.189 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 6.521568e-01 | 0.186 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.524198e-01 | 0.185 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.524198e-01 | 0.185 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.533281e-01 | 0.185 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.533281e-01 | 0.185 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.533281e-01 | 0.185 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.533281e-01 | 0.185 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.540344e-01 | 0.184 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.625865e-01 | 0.179 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.625865e-01 | 0.179 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.625865e-01 | 0.179 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.625865e-01 | 0.179 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.626898e-01 | 0.179 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.632278e-01 | 0.178 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.669287e-01 | 0.176 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.677958e-01 | 0.175 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.677958e-01 | 0.175 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.677958e-01 | 0.175 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.718904e-01 | 0.173 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.718904e-01 | 0.173 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.718904e-01 | 0.173 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.734510e-01 | 0.172 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.735374e-01 | 0.172 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.735374e-01 | 0.172 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.758077e-01 | 0.170 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.758077e-01 | 0.170 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.758077e-01 | 0.170 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 6.758077e-01 | 0.170 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.758077e-01 | 0.170 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.758077e-01 | 0.170 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.758077e-01 | 0.170 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.758077e-01 | 0.170 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.758077e-01 | 0.170 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.758077e-01 | 0.170 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.758077e-01 | 0.170 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.758077e-01 | 0.170 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.758077e-01 | 0.170 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.780104e-01 | 0.169 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.780104e-01 | 0.169 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.780104e-01 | 0.169 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.780104e-01 | 0.169 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.780104e-01 | 0.169 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.795476e-01 | 0.168 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.809043e-01 | 0.167 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.837563e-01 | 0.165 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.857559e-01 | 0.164 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.857559e-01 | 0.164 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.857559e-01 | 0.164 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.879271e-01 | 0.162 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.879271e-01 | 0.162 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.879271e-01 | 0.162 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 6.879271e-01 | 0.162 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.879271e-01 | 0.162 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.879271e-01 | 0.162 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.879271e-01 | 0.162 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.879271e-01 | 0.162 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.879271e-01 | 0.162 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.879271e-01 | 0.162 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.906262e-01 | 0.161 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.906262e-01 | 0.161 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.906262e-01 | 0.161 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.918823e-01 | 0.160 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.918823e-01 | 0.160 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.002498e-01 | 0.155 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.002806e-01 | 0.155 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.002806e-01 | 0.155 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.013652e-01 | 0.154 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.013652e-01 | 0.154 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.013652e-01 | 0.154 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.039319e-01 | 0.152 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.039734e-01 | 0.152 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.039734e-01 | 0.152 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.039734e-01 | 0.152 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.041010e-01 | 0.152 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.041010e-01 | 0.152 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.041010e-01 | 0.152 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.041010e-01 | 0.152 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.041010e-01 | 0.152 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.041010e-01 | 0.152 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.041010e-01 | 0.152 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.041010e-01 | 0.152 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.041010e-01 | 0.152 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.041010e-01 | 0.152 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.041010e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.041010e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.041010e-01 | 0.152 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.041010e-01 | 0.152 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.050199e-01 | 0.152 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.050199e-01 | 0.152 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.120895e-01 | 0.147 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.141239e-01 | 0.146 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.157581e-01 | 0.145 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.189684e-01 | 0.143 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.234054e-01 | 0.141 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.234054e-01 | 0.141 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.234054e-01 | 0.141 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.234054e-01 | 0.141 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.234054e-01 | 0.141 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.234054e-01 | 0.141 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.254174e-01 | 0.139 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.258143e-01 | 0.139 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.258143e-01 | 0.139 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.258143e-01 | 0.139 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.258143e-01 | 0.139 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.258143e-01 | 0.139 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.258143e-01 | 0.139 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.258143e-01 | 0.139 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.258143e-01 | 0.139 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.258143e-01 | 0.139 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.258143e-01 | 0.139 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.258143e-01 | 0.139 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.258143e-01 | 0.139 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.258143e-01 | 0.139 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.258143e-01 | 0.139 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.258626e-01 | 0.139 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.258626e-01 | 0.139 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.258626e-01 | 0.139 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.271075e-01 | 0.138 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.301843e-01 | 0.137 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 7.303052e-01 | 0.136 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.303052e-01 | 0.136 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.303052e-01 | 0.136 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.303052e-01 | 0.136 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.303052e-01 | 0.136 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.303052e-01 | 0.136 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.303052e-01 | 0.136 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.303052e-01 | 0.136 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.303052e-01 | 0.136 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.398956e-01 | 0.131 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.415533e-01 | 0.130 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.415533e-01 | 0.130 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.423597e-01 | 0.129 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.423597e-01 | 0.129 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.424927e-01 | 0.129 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.435331e-01 | 0.129 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.441535e-01 | 0.128 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.441535e-01 | 0.128 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.441535e-01 | 0.128 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.441535e-01 | 0.128 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.483372e-01 | 0.126 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.486433e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.491474e-01 | 0.125 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.491474e-01 | 0.125 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.491474e-01 | 0.125 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.491474e-01 | 0.125 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.545103e-01 | 0.122 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.545103e-01 | 0.122 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.545103e-01 | 0.122 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.545103e-01 | 0.122 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.545103e-01 | 0.122 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.546145e-01 | 0.122 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.565704e-01 | 0.121 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.581137e-01 | 0.120 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.581137e-01 | 0.120 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.581137e-01 | 0.120 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.589330e-01 | 0.120 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.591037e-01 | 0.120 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.591037e-01 | 0.120 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.591037e-01 | 0.120 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.591037e-01 | 0.120 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.591037e-01 | 0.120 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.591037e-01 | 0.120 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.591037e-01 | 0.120 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.591037e-01 | 0.120 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.591037e-01 | 0.120 | 0 | 0 |
| Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 | R-HSA-211957 | 7.591037e-01 | 0.120 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.591037e-01 | 0.120 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.591037e-01 | 0.120 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.591037e-01 | 0.120 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.591037e-01 | 0.120 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.591037e-01 | 0.120 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.591037e-01 | 0.120 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.591037e-01 | 0.120 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.591037e-01 | 0.120 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.591037e-01 | 0.120 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.591037e-01 | 0.120 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.591037e-01 | 0.120 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.591037e-01 | 0.120 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.593387e-01 | 0.120 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.617247e-01 | 0.118 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.636403e-01 | 0.117 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.636403e-01 | 0.117 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.636403e-01 | 0.117 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.636403e-01 | 0.117 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.636403e-01 | 0.117 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.646409e-01 | 0.117 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.654512e-01 | 0.116 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.694907e-01 | 0.114 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.731326e-01 | 0.112 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.731326e-01 | 0.112 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.731326e-01 | 0.112 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.731326e-01 | 0.112 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.743840e-01 | 0.111 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.753923e-01 | 0.110 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.753923e-01 | 0.110 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.753923e-01 | 0.110 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.768154e-01 | 0.110 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.768154e-01 | 0.110 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.768154e-01 | 0.110 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.819030e-01 | 0.107 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.819030e-01 | 0.107 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.838438e-01 | 0.106 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.864210e-01 | 0.104 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.869328e-01 | 0.104 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.869328e-01 | 0.104 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.874271e-01 | 0.104 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.878184e-01 | 0.104 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.878184e-01 | 0.104 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.883531e-01 | 0.103 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.883531e-01 | 0.103 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.883531e-01 | 0.103 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.883531e-01 | 0.103 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.883531e-01 | 0.103 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.883531e-01 | 0.103 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.883531e-01 | 0.103 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.883531e-01 | 0.103 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.883531e-01 | 0.103 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.884060e-01 | 0.103 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.905074e-01 | 0.102 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.909513e-01 | 0.102 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.973250e-01 | 0.098 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 7.973250e-01 | 0.098 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 7.973250e-01 | 0.098 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.973250e-01 | 0.098 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.973250e-01 | 0.098 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.973250e-01 | 0.098 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.987634e-01 | 0.098 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.987634e-01 | 0.098 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.995309e-01 | 0.097 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.010106e-01 | 0.096 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.029815e-01 | 0.095 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.037242e-01 | 0.095 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.056336e-01 | 0.094 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.056336e-01 | 0.094 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.100874e-01 | 0.091 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.102102e-01 | 0.091 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.111182e-01 | 0.091 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.124952e-01 | 0.090 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.133429e-01 | 0.090 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.133429e-01 | 0.090 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.138991e-01 | 0.089 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.140526e-01 | 0.089 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.140526e-01 | 0.089 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.140526e-01 | 0.089 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.140526e-01 | 0.089 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.140526e-01 | 0.089 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.140526e-01 | 0.089 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.140526e-01 | 0.089 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.140526e-01 | 0.089 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.140526e-01 | 0.089 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.140526e-01 | 0.089 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.140526e-01 | 0.089 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.140526e-01 | 0.089 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.140526e-01 | 0.089 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 8.140526e-01 | 0.089 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.140526e-01 | 0.089 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.140526e-01 | 0.089 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.140526e-01 | 0.089 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.140526e-01 | 0.089 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.140526e-01 | 0.089 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.140526e-01 | 0.089 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.140526e-01 | 0.089 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.140526e-01 | 0.089 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.144237e-01 | 0.089 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.149287e-01 | 0.089 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.149287e-01 | 0.089 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.161462e-01 | 0.088 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.161462e-01 | 0.088 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.161462e-01 | 0.088 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.161462e-01 | 0.088 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.161462e-01 | 0.088 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.161462e-01 | 0.088 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.161462e-01 | 0.088 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.161462e-01 | 0.088 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.161462e-01 | 0.088 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.183951e-01 | 0.087 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.188695e-01 | 0.087 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.218182e-01 | 0.085 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.261102e-01 | 0.083 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.271488e-01 | 0.082 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.276445e-01 | 0.082 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.297869e-01 | 0.081 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.297869e-01 | 0.081 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.297869e-01 | 0.081 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.317275e-01 | 0.080 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.330950e-01 | 0.079 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.333866e-01 | 0.079 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.333866e-01 | 0.079 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.333866e-01 | 0.079 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.333866e-01 | 0.079 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.333866e-01 | 0.079 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.333866e-01 | 0.079 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.333866e-01 | 0.079 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.333866e-01 | 0.079 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.333866e-01 | 0.079 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.333866e-01 | 0.079 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.335189e-01 | 0.079 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.365459e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.365459e-01 | 0.078 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.366328e-01 | 0.077 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.366328e-01 | 0.077 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.366328e-01 | 0.077 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.366328e-01 | 0.077 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.366328e-01 | 0.077 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.366328e-01 | 0.077 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.366328e-01 | 0.077 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.366328e-01 | 0.077 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.376633e-01 | 0.077 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.385173e-01 | 0.076 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.409317e-01 | 0.075 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.433660e-01 | 0.074 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.438919e-01 | 0.074 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.446933e-01 | 0.073 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.446933e-01 | 0.073 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.491524e-01 | 0.071 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.491524e-01 | 0.071 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.491524e-01 | 0.071 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.491524e-01 | 0.071 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.512058e-01 | 0.070 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.537337e-01 | 0.069 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.553343e-01 | 0.068 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.561511e-01 | 0.067 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.561511e-01 | 0.067 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.564463e-01 | 0.067 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.564721e-01 | 0.067 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.564721e-01 | 0.067 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.564721e-01 | 0.067 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.564721e-01 | 0.067 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.564721e-01 | 0.067 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.564721e-01 | 0.067 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.628883e-01 | 0.064 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.635475e-01 | 0.064 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.635475e-01 | 0.064 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.635475e-01 | 0.064 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.648650e-01 | 0.063 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.651753e-01 | 0.063 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.668810e-01 | 0.062 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.668810e-01 | 0.062 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.683515e-01 | 0.061 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.685858e-01 | 0.061 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.718891e-01 | 0.060 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.730795e-01 | 0.059 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.739032e-01 | 0.059 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.739032e-01 | 0.059 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.739032e-01 | 0.059 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.739032e-01 | 0.059 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.739032e-01 | 0.059 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.739032e-01 | 0.059 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.739032e-01 | 0.059 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.739032e-01 | 0.059 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 8.739032e-01 | 0.059 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.739032e-01 | 0.059 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.739032e-01 | 0.059 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.739032e-01 | 0.059 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.739032e-01 | 0.059 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.739032e-01 | 0.059 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.739032e-01 | 0.059 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.739032e-01 | 0.059 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.739032e-01 | 0.059 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.762558e-01 | 0.057 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.766722e-01 | 0.057 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.766722e-01 | 0.057 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.766722e-01 | 0.057 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.766722e-01 | 0.057 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.769157e-01 | 0.057 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.769157e-01 | 0.057 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.770423e-01 | 0.057 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.777224e-01 | 0.057 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.801209e-01 | 0.055 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.862882e-01 | 0.052 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.862882e-01 | 0.052 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.863123e-01 | 0.052 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.881219e-01 | 0.052 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.881219e-01 | 0.052 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.881219e-01 | 0.052 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.886226e-01 | 0.051 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.886226e-01 | 0.051 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.886226e-01 | 0.051 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.892182e-01 | 0.051 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.892182e-01 | 0.051 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.892182e-01 | 0.051 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.892182e-01 | 0.051 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.892182e-01 | 0.051 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.892182e-01 | 0.051 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.892182e-01 | 0.051 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.892182e-01 | 0.051 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.892182e-01 | 0.051 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.892182e-01 | 0.051 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.892182e-01 | 0.051 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.895720e-01 | 0.051 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.914861e-01 | 0.050 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.925524e-01 | 0.049 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.931505e-01 | 0.049 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.943788e-01 | 0.048 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.951905e-01 | 0.048 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.978044e-01 | 0.047 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.979740e-01 | 0.047 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.989887e-01 | 0.046 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.989887e-01 | 0.046 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.989887e-01 | 0.046 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.994905e-01 | 0.046 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.994905e-01 | 0.046 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.011227e-01 | 0.045 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.019457e-01 | 0.045 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.026739e-01 | 0.044 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 9.026739e-01 | 0.044 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.026739e-01 | 0.044 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.026739e-01 | 0.044 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.026739e-01 | 0.044 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.026739e-01 | 0.044 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 9.026739e-01 | 0.044 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.026739e-01 | 0.044 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.026739e-01 | 0.044 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.026739e-01 | 0.044 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.026739e-01 | 0.044 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.031781e-01 | 0.044 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.081979e-01 | 0.042 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.091777e-01 | 0.041 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.093623e-01 | 0.041 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.093623e-01 | 0.041 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.107602e-01 | 0.041 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.107602e-01 | 0.041 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.107602e-01 | 0.041 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.107602e-01 | 0.041 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.118723e-01 | 0.040 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.136413e-01 | 0.039 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.144960e-01 | 0.039 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 9.144960e-01 | 0.039 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 9.144960e-01 | 0.039 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.144960e-01 | 0.039 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.144960e-01 | 0.039 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.144960e-01 | 0.039 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.144960e-01 | 0.039 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.144960e-01 | 0.039 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.144960e-01 | 0.039 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.144960e-01 | 0.039 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.148296e-01 | 0.039 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.156735e-01 | 0.038 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.156735e-01 | 0.038 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.156735e-01 | 0.038 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.156790e-01 | 0.038 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.159034e-01 | 0.038 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.162545e-01 | 0.038 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.172548e-01 | 0.038 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.178090e-01 | 0.037 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.183196e-01 | 0.037 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.183196e-01 | 0.037 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.183196e-01 | 0.037 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.183196e-01 | 0.037 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.212288e-01 | 0.036 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.230453e-01 | 0.035 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.230453e-01 | 0.035 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.230453e-01 | 0.035 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.230453e-01 | 0.035 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.239075e-01 | 0.034 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.243552e-01 | 0.034 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.246993e-01 | 0.034 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.248826e-01 | 0.034 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.248826e-01 | 0.034 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.248826e-01 | 0.034 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.248826e-01 | 0.034 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.248826e-01 | 0.034 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.248826e-01 | 0.034 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.264390e-01 | 0.033 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.264390e-01 | 0.033 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.264390e-01 | 0.033 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.264390e-01 | 0.033 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.264390e-01 | 0.033 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.264390e-01 | 0.033 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.264390e-01 | 0.033 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.269721e-01 | 0.033 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.270069e-01 | 0.033 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.276791e-01 | 0.033 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.292542e-01 | 0.032 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.292542e-01 | 0.032 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.298177e-01 | 0.032 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.298177e-01 | 0.032 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.304285e-01 | 0.031 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.307398e-01 | 0.031 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.330914e-01 | 0.030 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.330914e-01 | 0.030 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.337917e-01 | 0.030 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.337917e-01 | 0.030 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.337917e-01 | 0.030 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.340081e-01 | 0.030 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.340081e-01 | 0.030 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.340081e-01 | 0.030 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.340081e-01 | 0.030 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.340081e-01 | 0.030 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.340081e-01 | 0.030 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.340081e-01 | 0.030 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.340081e-01 | 0.030 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.340081e-01 | 0.030 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.340081e-01 | 0.030 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.340081e-01 | 0.030 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.360377e-01 | 0.029 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.360377e-01 | 0.029 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.360574e-01 | 0.029 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.360574e-01 | 0.029 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.360574e-01 | 0.029 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.371819e-01 | 0.028 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.404442e-01 | 0.027 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.404442e-01 | 0.027 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.404442e-01 | 0.027 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.406546e-01 | 0.027 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.408147e-01 | 0.026 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.417450e-01 | 0.026 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.417450e-01 | 0.026 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.417450e-01 | 0.026 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.417450e-01 | 0.026 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.420254e-01 | 0.026 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.420254e-01 | 0.026 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.420254e-01 | 0.026 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.420254e-01 | 0.026 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.420254e-01 | 0.026 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.420254e-01 | 0.026 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.420254e-01 | 0.026 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.420254e-01 | 0.026 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.427233e-01 | 0.026 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.429921e-01 | 0.025 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.454199e-01 | 0.024 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.457203e-01 | 0.024 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.464580e-01 | 0.024 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.464580e-01 | 0.024 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.464580e-01 | 0.024 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.464580e-01 | 0.024 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.469767e-01 | 0.024 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.469767e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.490692e-01 | 0.023 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.490692e-01 | 0.023 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.490692e-01 | 0.023 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.490692e-01 | 0.023 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.505481e-01 | 0.022 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.505481e-01 | 0.022 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.517016e-01 | 0.021 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.518747e-01 | 0.021 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.518901e-01 | 0.021 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.529788e-01 | 0.021 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.546640e-01 | 0.020 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.546640e-01 | 0.020 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.552575e-01 | 0.020 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.552575e-01 | 0.020 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.552575e-01 | 0.020 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.552575e-01 | 0.020 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.552575e-01 | 0.020 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.552575e-01 | 0.020 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.552575e-01 | 0.020 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.552575e-01 | 0.020 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.565119e-01 | 0.019 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.578436e-01 | 0.019 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.578605e-01 | 0.019 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.584618e-01 | 0.018 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.584618e-01 | 0.018 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.601622e-01 | 0.018 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.606942e-01 | 0.017 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.606942e-01 | 0.017 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.606942e-01 | 0.017 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.606942e-01 | 0.017 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.606942e-01 | 0.017 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.607296e-01 | 0.017 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.612152e-01 | 0.017 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.612152e-01 | 0.017 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.619635e-01 | 0.017 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.652010e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.652010e-01 | 0.015 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.652010e-01 | 0.015 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.654705e-01 | 0.015 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.654705e-01 | 0.015 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.655203e-01 | 0.015 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.663039e-01 | 0.015 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.671688e-01 | 0.014 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.681680e-01 | 0.014 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.687911e-01 | 0.014 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.687911e-01 | 0.014 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.687911e-01 | 0.014 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.687911e-01 | 0.014 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.687911e-01 | 0.014 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.687911e-01 | 0.014 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.696667e-01 | 0.013 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.696667e-01 | 0.013 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.696667e-01 | 0.013 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.696667e-01 | 0.013 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.696667e-01 | 0.013 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 9.696667e-01 | 0.013 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.699731e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.702191e-01 | 0.013 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.720228e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.720228e-01 | 0.012 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.726627e-01 | 0.012 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.729997e-01 | 0.012 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.733532e-01 | 0.012 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.733532e-01 | 0.012 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.733532e-01 | 0.012 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.733532e-01 | 0.012 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.749303e-01 | 0.011 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.749303e-01 | 0.011 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.749303e-01 | 0.011 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.749303e-01 | 0.011 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.755329e-01 | 0.011 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.755329e-01 | 0.011 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.757098e-01 | 0.011 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.765918e-01 | 0.010 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.765918e-01 | 0.010 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.765918e-01 | 0.010 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.765918e-01 | 0.010 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.765918e-01 | 0.010 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.768205e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.775445e-01 | 0.010 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.778277e-01 | 0.010 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.778277e-01 | 0.010 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.794370e-01 | 0.009 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.794370e-01 | 0.009 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.794370e-01 | 0.009 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.794370e-01 | 0.009 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.794370e-01 | 0.009 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.795849e-01 | 0.009 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.798150e-01 | 0.009 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.804804e-01 | 0.009 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.818394e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.819365e-01 | 0.008 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.819365e-01 | 0.008 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.819365e-01 | 0.008 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.820039e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.820039e-01 | 0.008 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.823486e-01 | 0.008 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.841323e-01 | 0.007 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.852060e-01 | 0.006 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.852581e-01 | 0.006 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.855981e-01 | 0.006 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.860478e-01 | 0.006 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.860613e-01 | 0.006 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.868390e-01 | 0.006 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.871228e-01 | 0.006 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.871228e-01 | 0.006 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.877559e-01 | 0.005 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.877559e-01 | 0.005 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.877559e-01 | 0.005 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.878778e-01 | 0.005 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.880147e-01 | 0.005 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.881013e-01 | 0.005 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.892446e-01 | 0.005 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.894974e-01 | 0.005 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.897147e-01 | 0.004 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.897147e-01 | 0.004 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.900091e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.904433e-01 | 0.004 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.905523e-01 | 0.004 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.908121e-01 | 0.004 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.911001e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.911001e-01 | 0.004 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.911001e-01 | 0.004 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.917011e-01 | 0.004 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.917011e-01 | 0.004 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.917011e-01 | 0.004 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.917011e-01 | 0.004 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.917947e-01 | 0.004 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.917947e-01 | 0.004 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.917947e-01 | 0.004 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.924524e-01 | 0.003 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.926743e-01 | 0.003 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.926743e-01 | 0.003 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.926743e-01 | 0.003 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.926743e-01 | 0.003 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.927103e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.930293e-01 | 0.003 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.934627e-01 | 0.003 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.934953e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.939816e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.940377e-01 | 0.003 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.940972e-01 | 0.003 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.943755e-01 | 0.002 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.947801e-01 | 0.002 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.950596e-01 | 0.002 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.950596e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.950596e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.951443e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.953622e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.954901e-01 | 0.002 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.955982e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.955982e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.956605e-01 | 0.002 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.956605e-01 | 0.002 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.956605e-01 | 0.002 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.958607e-01 | 0.002 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.958607e-01 | 0.002 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.958607e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.960111e-01 | 0.002 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.960111e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.961572e-01 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.961572e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.961884e-01 | 0.002 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.961884e-01 | 0.002 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.963100e-01 | 0.002 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.963100e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.965173e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.966520e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.966520e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.966520e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.968117e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.970593e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.972609e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.973185e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.974171e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.974171e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.974682e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.975279e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.975373e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.977248e-01 | 0.001 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.977313e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.977313e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.979294e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.980074e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.980074e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.982385e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.983589e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.983589e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.983789e-01 | 0.001 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.984628e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.984628e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.985200e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.986499e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.986519e-01 | 0.001 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.986771e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.988142e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.988142e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.989308e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.989585e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.989715e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.991218e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.991966e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.992172e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.993558e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.993572e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.993572e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.993572e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.993803e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.993803e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.993857e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.993857e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.994287e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.994419e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.994558e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.994586e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.994767e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.995601e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.995793e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.995914e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.995992e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.995992e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.996004e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.996313e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.996528e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.996721e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.996838e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997192e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.997445e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.997503e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.997507e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997735e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.997807e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.998256e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.998515e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.998515e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.998515e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998689e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.998696e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998781e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998958e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.998994e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999117e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999117e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999117e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999136e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999168e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999224e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999407e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999475e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999528e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999624e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999644e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999688e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999727e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999738e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999762e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999788e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999832e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999903e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999920e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999933e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999934e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999935e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999956e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999966e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999969e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999977e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999982e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999991e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999991e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999991e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999997e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.330669e-16 | 15.477 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.839773e-14 | 13.234 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.259260e-14 | 13.033 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.095790e-13 | 12.960 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.416156e-13 | 12.466 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.204015e-11 | 10.919 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.306499e-11 | 10.884 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.564837e-11 | 10.255 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.155765e-10 | 9.937 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.103568e-10 | 9.957 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.633933e-10 | 9.787 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.645811e-10 | 9.784 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.015448e-10 | 9.696 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.828468e-10 | 9.417 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.092361e-10 | 9.293 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.809554e-10 | 9.055 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.002965e-09 | 8.999 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.161895e-09 | 8.935 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.715369e-09 | 8.766 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.825908e-09 | 8.739 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.258069e-09 | 8.646 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.352807e-09 | 8.628 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.532909e-09 | 8.596 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.576358e-09 | 8.447 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.608906e-09 | 8.336 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.595926e-09 | 8.252 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.488813e-09 | 8.261 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.994113e-09 | 8.222 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.156364e-09 | 8.211 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.707788e-09 | 8.173 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.430869e-09 | 8.025 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 9.749006e-09 | 8.011 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.193153e-08 | 7.923 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.350947e-08 | 7.869 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.399632e-08 | 7.854 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.709234e-08 | 7.767 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.787883e-08 | 7.748 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.912210e-08 | 7.718 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.912210e-08 | 7.718 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.871003e-08 | 7.728 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.317061e-08 | 7.635 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.965536e-08 | 7.528 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.509702e-08 | 7.455 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.468051e-08 | 7.460 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.469695e-08 | 7.460 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.322700e-08 | 7.364 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.424582e-08 | 7.354 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.970968e-08 | 7.304 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.970968e-08 | 7.304 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.059576e-08 | 7.218 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.059576e-08 | 7.218 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.037439e-08 | 7.153 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.547697e-08 | 7.122 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.547697e-08 | 7.122 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.560647e-08 | 7.121 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.921730e-08 | 7.101 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.852224e-08 | 7.105 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.919986e-08 | 7.050 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.483187e-08 | 7.023 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.167005e-07 | 6.933 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.231092e-07 | 6.910 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.344777e-07 | 6.871 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.377720e-07 | 6.861 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.615364e-07 | 6.792 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.791387e-07 | 6.747 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.807916e-07 | 6.743 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.932778e-07 | 6.714 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.873446e-07 | 6.727 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.008529e-07 | 6.697 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.047742e-07 | 6.689 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.187902e-07 | 6.660 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.187902e-07 | 6.660 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.713468e-07 | 6.566 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.246798e-07 | 6.489 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.393244e-07 | 6.469 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.610719e-07 | 6.442 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.730046e-07 | 6.428 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.750882e-07 | 6.323 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.673448e-07 | 6.330 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.377813e-07 | 6.269 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.430902e-07 | 6.265 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.257563e-07 | 6.083 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.158822e-07 | 6.088 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.476585e-07 | 6.072 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.957711e-07 | 6.002 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.236876e-06 | 5.908 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.195823e-06 | 5.922 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.195823e-06 | 5.922 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.345219e-06 | 5.871 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.455513e-06 | 5.837 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.544102e-06 | 5.811 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.736260e-06 | 5.760 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.718675e-06 | 5.765 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.706389e-06 | 5.768 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.767919e-06 | 5.753 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.828422e-06 | 5.738 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.828422e-06 | 5.738 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.098001e-06 | 5.678 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.098001e-06 | 5.678 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.051078e-06 | 5.688 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.053391e-06 | 5.688 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.361849e-06 | 5.627 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.441711e-06 | 5.612 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.724423e-06 | 5.565 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.021746e-06 | 5.520 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.287687e-06 | 5.483 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.122298e-06 | 5.506 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.108459e-06 | 5.507 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.290203e-06 | 5.483 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.539369e-06 | 5.451 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.621538e-06 | 5.441 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.621538e-06 | 5.441 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.621719e-06 | 5.441 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.366845e-06 | 5.360 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.016006e-06 | 5.300 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.707783e-06 | 5.327 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.201321e-06 | 5.284 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.372796e-06 | 5.270 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.478974e-06 | 5.261 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.836924e-06 | 5.234 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.836924e-06 | 5.234 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.032147e-06 | 5.220 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.712121e-06 | 5.173 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.357049e-06 | 5.197 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.222052e-06 | 5.206 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.131385e-06 | 5.147 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.417458e-06 | 5.130 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.602997e-06 | 5.065 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.924939e-06 | 5.049 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.924939e-06 | 5.049 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.133908e-06 | 5.039 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.220974e-06 | 5.035 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.586002e-06 | 5.018 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.744946e-06 | 5.011 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.986776e-06 | 5.001 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.025465e-05 | 4.989 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.107250e-05 | 4.956 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.092591e-05 | 4.962 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.191125e-05 | 4.924 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.209835e-05 | 4.917 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.317594e-05 | 4.880 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.353248e-05 | 4.869 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.479405e-05 | 4.830 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.479755e-05 | 4.830 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.509071e-05 | 4.821 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.740689e-05 | 4.759 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.656233e-05 | 4.781 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.648445e-05 | 4.783 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.680187e-05 | 4.775 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.643253e-05 | 4.784 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.734950e-05 | 4.761 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.746175e-05 | 4.758 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.748101e-05 | 4.757 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.940276e-05 | 4.712 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.962803e-05 | 4.707 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.244590e-05 | 4.649 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.246451e-05 | 4.649 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.310806e-05 | 4.636 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.410746e-05 | 4.618 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.418511e-05 | 4.616 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.457966e-05 | 4.609 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.756329e-05 | 4.560 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.092312e-05 | 4.510 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.364480e-05 | 4.473 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.192509e-05 | 4.496 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.411712e-05 | 4.467 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.411712e-05 | 4.467 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.700534e-05 | 4.432 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.705637e-05 | 4.431 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.052410e-05 | 4.392 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.054751e-05 | 4.392 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.261015e-05 | 4.370 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.261015e-05 | 4.370 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.261015e-05 | 4.370 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.422117e-05 | 4.354 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.675499e-05 | 4.330 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.755424e-05 | 4.323 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.004252e-05 | 4.301 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.375883e-05 | 4.270 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.064291e-05 | 4.217 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.186494e-05 | 4.209 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.343481e-05 | 4.198 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.705045e-05 | 4.113 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.273861e-05 | 4.082 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.904125e-05 | 4.050 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.037459e-04 | 3.984 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.052115e-04 | 3.978 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.090268e-04 | 3.962 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.135826e-04 | 3.945 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.209403e-04 | 3.917 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.236802e-04 | 3.908 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.239844e-04 | 3.907 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.344486e-04 | 3.871 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.477119e-04 | 3.831 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.711901e-04 | 3.767 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.759327e-04 | 3.755 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.821054e-04 | 3.740 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.852796e-04 | 3.732 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.859163e-04 | 3.731 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.913653e-04 | 3.718 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.954250e-04 | 3.709 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.988941e-04 | 3.701 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.123772e-04 | 3.673 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.230250e-04 | 3.652 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.946183e-04 | 3.531 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.013379e-04 | 3.521 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.289151e-04 | 3.483 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.632114e-04 | 3.440 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.632114e-04 | 3.440 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.642631e-04 | 3.439 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.788200e-04 | 3.422 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.819619e-04 | 3.418 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.819619e-04 | 3.418 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.914949e-04 | 3.407 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.153481e-04 | 3.382 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.192340e-04 | 3.378 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.226204e-04 | 3.374 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.241571e-04 | 3.372 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.337196e-04 | 3.363 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.375262e-04 | 3.359 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.403989e-04 | 3.356 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.406213e-04 | 3.356 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.639676e-04 | 3.334 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.664879e-04 | 3.331 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.783480e-04 | 3.320 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.809354e-04 | 3.318 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.006291e-04 | 3.300 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.424755e-04 | 3.266 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.487103e-04 | 3.261 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.264109e-04 | 3.279 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.126163e-04 | 3.290 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.424755e-04 | 3.266 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.815003e-04 | 3.235 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.264109e-04 | 3.279 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.969364e-04 | 3.224 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.048990e-04 | 3.218 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.235511e-04 | 3.205 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.323216e-04 | 3.199 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.585777e-04 | 3.181 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.585777e-04 | 3.181 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.585777e-04 | 3.181 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.929802e-04 | 3.159 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.161599e-04 | 3.145 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.161599e-04 | 3.145 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.571729e-04 | 3.121 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.581400e-04 | 3.120 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.927257e-04 | 3.101 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.371117e-04 | 3.077 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.588932e-04 | 3.066 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.588932e-04 | 3.066 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.075563e-04 | 3.042 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.376716e-04 | 3.028 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.376716e-04 | 3.028 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 9.443163e-04 | 3.025 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.443163e-04 | 3.025 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.547337e-04 | 3.020 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.091911e-03 | 2.962 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.028456e-03 | 2.988 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.695689e-04 | 3.013 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.026290e-03 | 2.989 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.150564e-03 | 2.939 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.124207e-03 | 2.949 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.201528e-03 | 2.920 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.209815e-03 | 2.917 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.251927e-03 | 2.902 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.283763e-03 | 2.892 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.392602e-03 | 2.856 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.431461e-03 | 2.844 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.480029e-03 | 2.830 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.531494e-03 | 2.815 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.531494e-03 | 2.815 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.537654e-03 | 2.813 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.570702e-03 | 2.804 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.688914e-03 | 2.772 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.776476e-03 | 2.750 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.776476e-03 | 2.750 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.808031e-03 | 2.743 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.808031e-03 | 2.743 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.854681e-03 | 2.732 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.013208e-03 | 2.696 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.072234e-03 | 2.684 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.177803e-03 | 2.662 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.242001e-03 | 2.649 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.330887e-03 | 2.632 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.403150e-03 | 2.619 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.464262e-03 | 2.608 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.499676e-03 | 2.602 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.499676e-03 | 2.602 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.590217e-03 | 2.587 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.939618e-03 | 2.532 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.719611e-03 | 2.565 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.991931e-03 | 2.524 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.304644e-03 | 2.481 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.119734e-03 | 2.506 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.320707e-03 | 2.479 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.452800e-03 | 2.462 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.485105e-03 | 2.458 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.656201e-03 | 2.437 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.696752e-03 | 2.432 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.772339e-03 | 2.423 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.776361e-03 | 2.423 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.776361e-03 | 2.423 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.792907e-03 | 2.421 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.792907e-03 | 2.421 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.812375e-03 | 2.419 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.946658e-03 | 2.404 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.013462e-03 | 2.396 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.046503e-03 | 2.393 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.070281e-03 | 2.390 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.264302e-03 | 2.370 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.264302e-03 | 2.370 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.541031e-03 | 2.343 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.541031e-03 | 2.343 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.541031e-03 | 2.343 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.577800e-03 | 2.339 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.577800e-03 | 2.339 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.577800e-03 | 2.339 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.710904e-03 | 2.327 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.736217e-03 | 2.325 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.737782e-03 | 2.324 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.796797e-03 | 2.319 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.796797e-03 | 2.319 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.973284e-03 | 2.303 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.105491e-03 | 2.292 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.105491e-03 | 2.292 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.374442e-03 | 2.270 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.469193e-03 | 2.262 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.492025e-03 | 2.260 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.528767e-03 | 2.257 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.535312e-03 | 2.257 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.535312e-03 | 2.257 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.560856e-03 | 2.255 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.560856e-03 | 2.255 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.917932e-03 | 2.228 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.091179e-03 | 2.215 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.205564e-03 | 2.207 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.205564e-03 | 2.207 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.210872e-03 | 2.207 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.210872e-03 | 2.207 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.210872e-03 | 2.207 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.210872e-03 | 2.207 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.289398e-03 | 2.201 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.475128e-03 | 2.189 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.475128e-03 | 2.189 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.442571e-03 | 2.074 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.614476e-03 | 2.065 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.614476e-03 | 2.065 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.614476e-03 | 2.065 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.594208e-03 | 2.066 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.189316e-03 | 2.087 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.589650e-03 | 2.120 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.699113e-03 | 2.174 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.978588e-03 | 2.098 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.833892e-03 | 2.054 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.594208e-03 | 2.066 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.594208e-03 | 2.066 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.939401e-03 | 2.100 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.777343e-03 | 2.169 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.134172e-03 | 2.090 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.383101e-03 | 2.132 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.168563e-03 | 2.145 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.699113e-03 | 2.174 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.908163e-03 | 2.161 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.445358e-03 | 2.128 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.445358e-03 | 2.128 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.846569e-03 | 2.053 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.861932e-03 | 2.052 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.161551e-03 | 2.038 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.305464e-03 | 2.031 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.510881e-03 | 2.022 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.551494e-03 | 2.020 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.551494e-03 | 2.020 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.661664e-03 | 2.015 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.661664e-03 | 2.015 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.661664e-03 | 2.015 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.661664e-03 | 2.015 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.999654e-03 | 2.000 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.016001e-02 | 1.993 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.016001e-02 | 1.993 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.016001e-02 | 1.993 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.016001e-02 | 1.993 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.025703e-02 | 1.989 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.030985e-02 | 1.987 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.030985e-02 | 1.987 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.050211e-02 | 1.979 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.108428e-02 | 1.955 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.108428e-02 | 1.955 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.113214e-02 | 1.953 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.113214e-02 | 1.953 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.133631e-02 | 1.946 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.185732e-02 | 1.926 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.205162e-02 | 1.919 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.205162e-02 | 1.919 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.209538e-02 | 1.917 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.233454e-02 | 1.909 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.233454e-02 | 1.909 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.278936e-02 | 1.893 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.287836e-02 | 1.890 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.287836e-02 | 1.890 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.290262e-02 | 1.889 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.319433e-02 | 1.880 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.372331e-02 | 1.863 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.399120e-02 | 1.854 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.448387e-02 | 1.839 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.458970e-02 | 1.836 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.512267e-02 | 1.820 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.528289e-02 | 1.816 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.534406e-02 | 1.814 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.538102e-02 | 1.813 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.550030e-02 | 1.810 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.550030e-02 | 1.810 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.550030e-02 | 1.810 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.570600e-02 | 1.804 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.570600e-02 | 1.804 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.572030e-02 | 1.804 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.572030e-02 | 1.804 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.572030e-02 | 1.804 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.572030e-02 | 1.804 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.572030e-02 | 1.804 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.604937e-02 | 1.795 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.651927e-02 | 1.782 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.660035e-02 | 1.780 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.765903e-02 | 1.753 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.848048e-02 | 1.733 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.854902e-02 | 1.732 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.900460e-02 | 1.721 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.941025e-02 | 1.712 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.970289e-02 | 1.705 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.970289e-02 | 1.705 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.976796e-02 | 1.704 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.031380e-02 | 1.692 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.031834e-02 | 1.692 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.104699e-02 | 1.677 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.138373e-02 | 1.670 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.138373e-02 | 1.670 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.138373e-02 | 1.670 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.169874e-02 | 1.664 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.179182e-02 | 1.662 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.257137e-02 | 1.646 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.300214e-02 | 1.638 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.346357e-02 | 1.630 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.346357e-02 | 1.630 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.346357e-02 | 1.630 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.610317e-02 | 1.583 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.629734e-02 | 1.580 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.629734e-02 | 1.580 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.817118e-02 | 1.550 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.817118e-02 | 1.550 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.844849e-02 | 1.546 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.844849e-02 | 1.546 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.844849e-02 | 1.546 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.882566e-02 | 1.540 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.325763e-02 | 1.478 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.325763e-02 | 1.478 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.950783e-02 | 1.530 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.610297e-02 | 1.442 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.584191e-02 | 1.446 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.584191e-02 | 1.446 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.299585e-02 | 1.367 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.318755e-02 | 1.479 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.440301e-02 | 1.463 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.947350e-02 | 1.404 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.947350e-02 | 1.404 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.419311e-02 | 1.466 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.355782e-02 | 1.361 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.169035e-02 | 1.499 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.523494e-02 | 1.453 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.145746e-02 | 1.382 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.890036e-02 | 1.410 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.355782e-02 | 1.361 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.715576e-02 | 1.430 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.145746e-02 | 1.382 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.950783e-02 | 1.530 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.584191e-02 | 1.446 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.738232e-02 | 1.427 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.369798e-02 | 1.360 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.325763e-02 | 1.478 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.275215e-02 | 1.485 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.946144e-02 | 1.531 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.650979e-02 | 1.438 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.174844e-02 | 1.498 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.114870e-02 | 1.386 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.355782e-02 | 1.361 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.745179e-02 | 1.427 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.947355e-02 | 1.531 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.419311e-02 | 1.466 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.523494e-02 | 1.453 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.231545e-02 | 1.491 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.610297e-02 | 1.442 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.440301e-02 | 1.463 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.947350e-02 | 1.404 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.429591e-02 | 1.465 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.610297e-02 | 1.442 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.745179e-02 | 1.427 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.097293e-02 | 1.509 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.145746e-02 | 1.382 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.689465e-02 | 1.433 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.313218e-02 | 1.480 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.222133e-02 | 1.492 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.369798e-02 | 1.360 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.715576e-02 | 1.430 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.610297e-02 | 1.442 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.500850e-02 | 1.347 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.520216e-02 | 1.345 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.520216e-02 | 1.345 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.559607e-02 | 1.341 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.608282e-02 | 1.336 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.627441e-02 | 1.335 | 1 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.698884e-02 | 1.328 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.772348e-02 | 1.321 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.881714e-02 | 1.311 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.945824e-02 | 1.306 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.094815e-02 | 1.293 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.094815e-02 | 1.293 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.094815e-02 | 1.293 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.101833e-02 | 1.292 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.101833e-02 | 1.292 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.101833e-02 | 1.292 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.210431e-02 | 1.283 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.210431e-02 | 1.283 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.475673e-02 | 1.262 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.562086e-02 | 1.255 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.562086e-02 | 1.255 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.562086e-02 | 1.255 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.562086e-02 | 1.255 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.562086e-02 | 1.255 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.562086e-02 | 1.255 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.562086e-02 | 1.255 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.562086e-02 | 1.255 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.562086e-02 | 1.255 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.562086e-02 | 1.255 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.562086e-02 | 1.255 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.562086e-02 | 1.255 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.633321e-02 | 1.249 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.751087e-02 | 1.240 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.751087e-02 | 1.240 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.850610e-02 | 1.233 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.961414e-02 | 1.225 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.961414e-02 | 1.225 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.970407e-02 | 1.224 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.970407e-02 | 1.224 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.052866e-02 | 1.218 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.052866e-02 | 1.218 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.190930e-02 | 1.208 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.196983e-02 | 1.208 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.199800e-02 | 1.208 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.199800e-02 | 1.208 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.199800e-02 | 1.208 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.199800e-02 | 1.208 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.199800e-02 | 1.208 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.449155e-02 | 1.190 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.449155e-02 | 1.190 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.684512e-02 | 1.175 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.684512e-02 | 1.175 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.684512e-02 | 1.175 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.773498e-02 | 1.169 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.789498e-02 | 1.168 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.789498e-02 | 1.168 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.926171e-02 | 1.160 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.982755e-02 | 1.156 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.022436e-02 | 1.154 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.022436e-02 | 1.154 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.102955e-02 | 1.149 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.196330e-02 | 1.143 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.257083e-02 | 1.139 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.374637e-02 | 1.132 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.386379e-02 | 1.132 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.386379e-02 | 1.132 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.646618e-02 | 1.117 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.646618e-02 | 1.117 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.935644e-02 | 1.100 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.935644e-02 | 1.100 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.961228e-02 | 1.099 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.961228e-02 | 1.099 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.990406e-02 | 1.097 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.990406e-02 | 1.097 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.992657e-02 | 1.097 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.992657e-02 | 1.097 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.992657e-02 | 1.097 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.992657e-02 | 1.097 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.097070e-02 | 1.092 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.114637e-02 | 1.091 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.114637e-02 | 1.091 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 8.179942e-02 | 1.087 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.577222e-02 | 1.067 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.580322e-02 | 1.066 | 1 | 1 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.580322e-02 | 1.066 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.636915e-02 | 1.064 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.636915e-02 | 1.064 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.636915e-02 | 1.064 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.741976e-02 | 1.058 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.741976e-02 | 1.058 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.753455e-02 | 1.058 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.981424e-02 | 1.047 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.007698e-02 | 1.045 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.074059e-02 | 1.042 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.074059e-02 | 1.042 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.074059e-02 | 1.042 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.074059e-02 | 1.042 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 9.294043e-02 | 1.032 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.354431e-02 | 1.029 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.693918e-02 | 1.014 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.731731e-02 | 1.012 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.731731e-02 | 1.012 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.731731e-02 | 1.012 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.731731e-02 | 1.012 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.949720e-02 | 1.002 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.026255e-01 | 0.989 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.026255e-01 | 0.989 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.026255e-01 | 0.989 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.031308e-01 | 0.987 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.048813e-01 | 0.979 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.054435e-01 | 0.977 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.061909e-01 | 0.974 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.061909e-01 | 0.974 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.061909e-01 | 0.974 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.061909e-01 | 0.974 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.061909e-01 | 0.974 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.061909e-01 | 0.974 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.062585e-01 | 0.974 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.067337e-01 | 0.972 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.067337e-01 | 0.972 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.067337e-01 | 0.972 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.109254e-01 | 0.955 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.109254e-01 | 0.955 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.109254e-01 | 0.955 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.109254e-01 | 0.955 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.109254e-01 | 0.955 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.152406e-01 | 0.938 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.166195e-01 | 0.933 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.166195e-01 | 0.933 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.173500e-01 | 0.931 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.173500e-01 | 0.931 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.196376e-01 | 0.922 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.196376e-01 | 0.922 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.231098e-01 | 0.910 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.231098e-01 | 0.910 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.231098e-01 | 0.910 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.232797e-01 | 0.909 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.236412e-01 | 0.908 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.236412e-01 | 0.908 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.278905e-01 | 0.893 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.281069e-01 | 0.892 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.285545e-01 | 0.891 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.315611e-01 | 0.881 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.315611e-01 | 0.881 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.335681e-01 | 0.874 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.335681e-01 | 0.874 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.720450e-01 | 0.764 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.720450e-01 | 0.764 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.720450e-01 | 0.764 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.466335e-01 | 0.608 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.466335e-01 | 0.608 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.466335e-01 | 0.608 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.466335e-01 | 0.608 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.466335e-01 | 0.608 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.422563e-01 | 0.847 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 1.422563e-01 | 0.847 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.090968e-01 | 0.680 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.090968e-01 | 0.680 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.090968e-01 | 0.680 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.436164e-01 | 0.613 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.436164e-01 | 0.613 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 2.436164e-01 | 0.613 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.436164e-01 | 0.613 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.936761e-01 | 0.713 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.568444e-01 | 0.805 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.568444e-01 | 0.805 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.177950e-01 | 0.662 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 2.177950e-01 | 0.662 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.571332e-01 | 0.804 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.128168e-01 | 0.672 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.675941e-01 | 0.573 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.756492e-01 | 0.755 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.553446e-01 | 0.593 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.108181e-01 | 0.676 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.231088e-01 | 0.651 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.519349e-01 | 0.599 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.627070e-01 | 0.581 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.483749e-01 | 0.829 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.553446e-01 | 0.593 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.076480e-01 | 0.683 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.527782e-01 | 0.597 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.936761e-01 | 0.713 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.723167e-01 | 0.764 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.477966e-01 | 0.830 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.748649e-01 | 0.757 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.379845e-01 | 0.623 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.477966e-01 | 0.830 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.880375e-01 | 0.726 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.935492e-01 | 0.713 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.850407e-01 | 0.733 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.395672e-01 | 0.855 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.936761e-01 | 0.713 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.108181e-01 | 0.676 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.254832e-01 | 0.647 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.867092e-01 | 0.729 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.935492e-01 | 0.713 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.108181e-01 | 0.676 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.047802e-01 | 0.689 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.720450e-01 | 0.764 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.751590e-01 | 0.757 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.748649e-01 | 0.757 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.424848e-01 | 0.615 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.726358e-01 | 0.763 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.091332e-01 | 0.680 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.096015e-01 | 0.679 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.670220e-01 | 0.777 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.492410e-01 | 0.603 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.400628e-01 | 0.620 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.936761e-01 | 0.713 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.751590e-01 | 0.757 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.538549e-01 | 0.813 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.537848e-01 | 0.813 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.823681e-01 | 0.739 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.493877e-01 | 0.826 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.880375e-01 | 0.726 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.489731e-01 | 0.827 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.108932e-01 | 0.676 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.379845e-01 | 0.623 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.379845e-01 | 0.623 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.363658e-01 | 0.865 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.128168e-01 | 0.672 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.231088e-01 | 0.651 | 0 | 0 |
| Translation | R-HSA-72766 | 1.379653e-01 | 0.860 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.590170e-01 | 0.799 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.720450e-01 | 0.764 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.466335e-01 | 0.608 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.466335e-01 | 0.608 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.477966e-01 | 0.830 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.436164e-01 | 0.613 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.424848e-01 | 0.615 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.424848e-01 | 0.615 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.675941e-01 | 0.573 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.401322e-01 | 0.853 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.239375e-01 | 0.650 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.390713e-01 | 0.621 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.390713e-01 | 0.621 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.379845e-01 | 0.623 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.474432e-01 | 0.831 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.631012e-01 | 0.580 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.518830e-01 | 0.818 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.645488e-01 | 0.784 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.377532e-01 | 0.861 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.477966e-01 | 0.830 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.751590e-01 | 0.757 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.090968e-01 | 0.680 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.436164e-01 | 0.613 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.806440e-01 | 0.743 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.946913e-01 | 0.711 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.946913e-01 | 0.711 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.606067e-01 | 0.794 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.347172e-01 | 0.871 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.379845e-01 | 0.623 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.379845e-01 | 0.623 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.702878e-01 | 0.769 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.108932e-01 | 0.676 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.466335e-01 | 0.608 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.751590e-01 | 0.757 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.936761e-01 | 0.713 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.675941e-01 | 0.573 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.675941e-01 | 0.573 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.606067e-01 | 0.794 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.379845e-01 | 0.623 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.500762e-01 | 0.824 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.379845e-01 | 0.623 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.182612e-01 | 0.661 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.416776e-01 | 0.849 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.935492e-01 | 0.713 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.513205e-01 | 0.600 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.401766e-01 | 0.619 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.531166e-01 | 0.815 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.751590e-01 | 0.757 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.655992e-01 | 0.781 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.492410e-01 | 0.603 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.379845e-01 | 0.623 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.551791e-01 | 0.593 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.568444e-01 | 0.805 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.436164e-01 | 0.613 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.395672e-01 | 0.855 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.675941e-01 | 0.573 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.450459e-01 | 0.611 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.751590e-01 | 0.757 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.325866e-01 | 0.633 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.566278e-01 | 0.805 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.676829e-01 | 0.572 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.701926e-01 | 0.568 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.701926e-01 | 0.568 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.701926e-01 | 0.568 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.701926e-01 | 0.568 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.704546e-01 | 0.568 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.733125e-01 | 0.563 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.783381e-01 | 0.555 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.783381e-01 | 0.555 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 2.783381e-01 | 0.555 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.783381e-01 | 0.555 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.783381e-01 | 0.555 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.783381e-01 | 0.555 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.810375e-01 | 0.551 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.861121e-01 | 0.543 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.871904e-01 | 0.542 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.880055e-01 | 0.541 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.897762e-01 | 0.538 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.897762e-01 | 0.538 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.929809e-01 | 0.533 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.929809e-01 | 0.533 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.935746e-01 | 0.532 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.935746e-01 | 0.532 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.941124e-01 | 0.531 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.941124e-01 | 0.531 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.015387e-01 | 0.521 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.022252e-01 | 0.520 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.022252e-01 | 0.520 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.022252e-01 | 0.520 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.090988e-01 | 0.510 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.097491e-01 | 0.509 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.129456e-01 | 0.505 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.129456e-01 | 0.505 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.129456e-01 | 0.505 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.129456e-01 | 0.505 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.129456e-01 | 0.505 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.129456e-01 | 0.505 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.129456e-01 | 0.505 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.129456e-01 | 0.505 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.129456e-01 | 0.505 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.129456e-01 | 0.505 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.129456e-01 | 0.505 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.129456e-01 | 0.505 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.145065e-01 | 0.502 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.145065e-01 | 0.502 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.145065e-01 | 0.502 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.145065e-01 | 0.502 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.145065e-01 | 0.502 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.145065e-01 | 0.502 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.145065e-01 | 0.502 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.151035e-01 | 0.502 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.151035e-01 | 0.502 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.184982e-01 | 0.497 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.184982e-01 | 0.497 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.185132e-01 | 0.497 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.185132e-01 | 0.497 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.185132e-01 | 0.497 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.185132e-01 | 0.497 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.185132e-01 | 0.497 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.190482e-01 | 0.496 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.238099e-01 | 0.490 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.247357e-01 | 0.488 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.319525e-01 | 0.479 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.348976e-01 | 0.475 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.348976e-01 | 0.475 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.362129e-01 | 0.473 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.362146e-01 | 0.473 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.368830e-01 | 0.473 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.440697e-01 | 0.463 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.440697e-01 | 0.463 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.440697e-01 | 0.463 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.440697e-01 | 0.463 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.440697e-01 | 0.463 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.449472e-01 | 0.462 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.471778e-01 | 0.459 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.471778e-01 | 0.459 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.471778e-01 | 0.459 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.471778e-01 | 0.459 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.471778e-01 | 0.459 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.471778e-01 | 0.459 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.471778e-01 | 0.459 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.471778e-01 | 0.459 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.471778e-01 | 0.459 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.513907e-01 | 0.454 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.573777e-01 | 0.447 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.573777e-01 | 0.447 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.584137e-01 | 0.446 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.586460e-01 | 0.445 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.679453e-01 | 0.434 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.695396e-01 | 0.432 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.695396e-01 | 0.432 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.695396e-01 | 0.432 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.695396e-01 | 0.432 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.695396e-01 | 0.432 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.695396e-01 | 0.432 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.695396e-01 | 0.432 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.762683e-01 | 0.425 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.762683e-01 | 0.425 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 3.762683e-01 | 0.425 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.762683e-01 | 0.425 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.762683e-01 | 0.425 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 3.762683e-01 | 0.425 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.762683e-01 | 0.425 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.785289e-01 | 0.422 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.785289e-01 | 0.422 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.785289e-01 | 0.422 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.785289e-01 | 0.422 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.785289e-01 | 0.422 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.808217e-01 | 0.419 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.808217e-01 | 0.419 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.808217e-01 | 0.419 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.808217e-01 | 0.419 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.808217e-01 | 0.419 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.808217e-01 | 0.419 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.808217e-01 | 0.419 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.826781e-01 | 0.417 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.948228e-01 | 0.404 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.948228e-01 | 0.404 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.957987e-01 | 0.403 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.996080e-01 | 0.398 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.003131e-01 | 0.398 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.011156e-01 | 0.397 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.011156e-01 | 0.397 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.081828e-01 | 0.389 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.082667e-01 | 0.389 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.103132e-01 | 0.387 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.137055e-01 | 0.383 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.137055e-01 | 0.383 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.137055e-01 | 0.383 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.137055e-01 | 0.383 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.137055e-01 | 0.383 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.137055e-01 | 0.383 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.137055e-01 | 0.383 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.142632e-01 | 0.383 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.146840e-01 | 0.382 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.154949e-01 | 0.381 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.194942e-01 | 0.377 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.198298e-01 | 0.377 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 4.198298e-01 | 0.377 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.198298e-01 | 0.377 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.198682e-01 | 0.377 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.205591e-01 | 0.376 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.205591e-01 | 0.376 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.230564e-01 | 0.374 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.239268e-01 | 0.373 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.324688e-01 | 0.364 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.324688e-01 | 0.364 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.324688e-01 | 0.364 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.324688e-01 | 0.364 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.324688e-01 | 0.364 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.324688e-01 | 0.364 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.324688e-01 | 0.364 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.324688e-01 | 0.364 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.324688e-01 | 0.364 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.377709e-01 | 0.359 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.412784e-01 | 0.355 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.413303e-01 | 0.355 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.413303e-01 | 0.355 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.413303e-01 | 0.355 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.444811e-01 | 0.352 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.444811e-01 | 0.352 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.444811e-01 | 0.352 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.444811e-01 | 0.352 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.456931e-01 | 0.351 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.456931e-01 | 0.351 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.456931e-01 | 0.351 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.456931e-01 | 0.351 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.456931e-01 | 0.351 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.456931e-01 | 0.351 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.456931e-01 | 0.351 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.456931e-01 | 0.351 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.456931e-01 | 0.351 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.456931e-01 | 0.351 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.456931e-01 | 0.351 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.505886e-01 | 0.346 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.505886e-01 | 0.346 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.505886e-01 | 0.346 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.582464e-01 | 0.339 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.618741e-01 | 0.335 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.659178e-01 | 0.332 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.687068e-01 | 0.329 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.687068e-01 | 0.329 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.704405e-01 | 0.327 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.766793e-01 | 0.322 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.766793e-01 | 0.322 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.766793e-01 | 0.322 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.766793e-01 | 0.322 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.766793e-01 | 0.322 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.766793e-01 | 0.322 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.830725e-01 | 0.316 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.836085e-01 | 0.316 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.836085e-01 | 0.316 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.836085e-01 | 0.316 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.836085e-01 | 0.316 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.836085e-01 | 0.316 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 4.836085e-01 | 0.316 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.836085e-01 | 0.316 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.836085e-01 | 0.316 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.836085e-01 | 0.316 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.836085e-01 | 0.316 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.836085e-01 | 0.316 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.836085e-01 | 0.316 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.836085e-01 | 0.316 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.836085e-01 | 0.316 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.883396e-01 | 0.311 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.883843e-01 | 0.311 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.905324e-01 | 0.309 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.916666e-01 | 0.308 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.924465e-01 | 0.308 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.924465e-01 | 0.308 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.943230e-01 | 0.306 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.949607e-01 | 0.305 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 4.950139e-01 | 0.305 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.000195e-01 | 0.301 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.021102e-01 | 0.299 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.021102e-01 | 0.299 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.021102e-01 | 0.299 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.021102e-01 | 0.299 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.021102e-01 | 0.299 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.052298e-01 | 0.297 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.063282e-01 | 0.296 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.065847e-01 | 0.295 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.065847e-01 | 0.295 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.065847e-01 | 0.295 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.065847e-01 | 0.295 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.104933e-01 | 0.292 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 5.149388e-01 | 0.288 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 5.156482e-01 | 0.288 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.161775e-01 | 0.287 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.161775e-01 | 0.287 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.161775e-01 | 0.287 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.197830e-01 | 0.284 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.217281e-01 | 0.283 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.265229e-01 | 0.279 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.278257e-01 | 0.278 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.301428e-01 | 0.276 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.301428e-01 | 0.276 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.301428e-01 | 0.276 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.301428e-01 | 0.276 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.301428e-01 | 0.276 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.301428e-01 | 0.276 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.301428e-01 | 0.276 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.301428e-01 | 0.276 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 5.301428e-01 | 0.276 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.301428e-01 | 0.276 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.301428e-01 | 0.276 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.301428e-01 | 0.276 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.301428e-01 | 0.276 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.301428e-01 | 0.276 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.301428e-01 | 0.276 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.301428e-01 | 0.276 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.301428e-01 | 0.276 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.301428e-01 | 0.276 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.311748e-01 | 0.275 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.341764e-01 | 0.272 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.353526e-01 | 0.271 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.353526e-01 | 0.271 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.353526e-01 | 0.271 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.353526e-01 | 0.271 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.353526e-01 | 0.271 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.409698e-01 | 0.267 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.435522e-01 | 0.265 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.435522e-01 | 0.265 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.482638e-01 | 0.261 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.506707e-01 | 0.259 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.602703e-01 | 0.252 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.602703e-01 | 0.252 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.602703e-01 | 0.252 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.602869e-01 | 0.252 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.624264e-01 | 0.250 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.629451e-01 | 0.250 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.629451e-01 | 0.250 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.629451e-01 | 0.250 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.629451e-01 | 0.250 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.629451e-01 | 0.250 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.629451e-01 | 0.250 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.629451e-01 | 0.250 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.629451e-01 | 0.250 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.629451e-01 | 0.250 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.629451e-01 | 0.250 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.629451e-01 | 0.250 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.637615e-01 | 0.249 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.645534e-01 | 0.248 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.724862e-01 | 0.242 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.724862e-01 | 0.242 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.724862e-01 | 0.242 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.724862e-01 | 0.242 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.724862e-01 | 0.242 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.724862e-01 | 0.242 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.724862e-01 | 0.242 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.724862e-01 | 0.242 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 5.724862e-01 | 0.242 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.724862e-01 | 0.242 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 5.724862e-01 | 0.242 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.724862e-01 | 0.242 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.782183e-01 | 0.238 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.782183e-01 | 0.238 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.801104e-01 | 0.236 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.816252e-01 | 0.235 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.816252e-01 | 0.235 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.816252e-01 | 0.235 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.822769e-01 | 0.235 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.892650e-01 | 0.230 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.893405e-01 | 0.230 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.893405e-01 | 0.230 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.893405e-01 | 0.230 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.893405e-01 | 0.230 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.893405e-01 | 0.230 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.893405e-01 | 0.230 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.911697e-01 | 0.228 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.927987e-01 | 0.227 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.961812e-01 | 0.225 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.961812e-01 | 0.225 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.019197e-01 | 0.220 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.019805e-01 | 0.220 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.023101e-01 | 0.220 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.023101e-01 | 0.220 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.023101e-01 | 0.220 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.053247e-01 | 0.218 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.085446e-01 | 0.216 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.085446e-01 | 0.216 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.110159e-01 | 0.214 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.110159e-01 | 0.214 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.110159e-01 | 0.214 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.110159e-01 | 0.214 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.110159e-01 | 0.214 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.110159e-01 | 0.214 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.110159e-01 | 0.214 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.110159e-01 | 0.214 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.110159e-01 | 0.214 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.110159e-01 | 0.214 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.110159e-01 | 0.214 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.136793e-01 | 0.212 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.136793e-01 | 0.212 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.145305e-01 | 0.211 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.145305e-01 | 0.211 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.145305e-01 | 0.211 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.145305e-01 | 0.211 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.223079e-01 | 0.206 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.223079e-01 | 0.206 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.223079e-01 | 0.206 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.223079e-01 | 0.206 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.306988e-01 | 0.200 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.333277e-01 | 0.198 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.385178e-01 | 0.195 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.385178e-01 | 0.195 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.385178e-01 | 0.195 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.385178e-01 | 0.195 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.385178e-01 | 0.195 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.416070e-01 | 0.193 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 6.416070e-01 | 0.193 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.460751e-01 | 0.190 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.460751e-01 | 0.190 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.460751e-01 | 0.190 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.460751e-01 | 0.190 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.460751e-01 | 0.190 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.460751e-01 | 0.190 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.460751e-01 | 0.190 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.460751e-01 | 0.190 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.460751e-01 | 0.190 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.460751e-01 | 0.190 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 6.460751e-01 | 0.190 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.460751e-01 | 0.190 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.460751e-01 | 0.190 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.465242e-01 | 0.189 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.472288e-01 | 0.189 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.472288e-01 | 0.189 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.602002e-01 | 0.180 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.613147e-01 | 0.180 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.613147e-01 | 0.180 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.632609e-01 | 0.178 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.692282e-01 | 0.174 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.779764e-01 | 0.169 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.779764e-01 | 0.169 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.779764e-01 | 0.169 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.779764e-01 | 0.169 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.779764e-01 | 0.169 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.779764e-01 | 0.169 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.779764e-01 | 0.169 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.779764e-01 | 0.169 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.779764e-01 | 0.169 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.779764e-01 | 0.169 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.779764e-01 | 0.169 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.779764e-01 | 0.169 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.779764e-01 | 0.169 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.780850e-01 | 0.169 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.790975e-01 | 0.168 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.829408e-01 | 0.166 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.829408e-01 | 0.166 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.829408e-01 | 0.166 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.938108e-01 | 0.159 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.952624e-01 | 0.158 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.952624e-01 | 0.158 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.964985e-01 | 0.157 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.980926e-01 | 0.156 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.994576e-01 | 0.155 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.014660e-01 | 0.154 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.014660e-01 | 0.154 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.019697e-01 | 0.154 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.019697e-01 | 0.154 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.034220e-01 | 0.153 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.034220e-01 | 0.153 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.034220e-01 | 0.153 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.053200e-01 | 0.152 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.070039e-01 | 0.151 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.070039e-01 | 0.151 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.070039e-01 | 0.151 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.070039e-01 | 0.151 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.070039e-01 | 0.151 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.070039e-01 | 0.151 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.070039e-01 | 0.151 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.070039e-01 | 0.151 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.082680e-01 | 0.150 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.090818e-01 | 0.149 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.117368e-01 | 0.148 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.209451e-01 | 0.142 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.209451e-01 | 0.142 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.227888e-01 | 0.141 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.227888e-01 | 0.141 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.227888e-01 | 0.141 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.275156e-01 | 0.138 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.275156e-01 | 0.138 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.275156e-01 | 0.138 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.304751e-01 | 0.136 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.334165e-01 | 0.135 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.334165e-01 | 0.135 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.334165e-01 | 0.135 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.334165e-01 | 0.135 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.334165e-01 | 0.135 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.334165e-01 | 0.135 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.334165e-01 | 0.135 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.334165e-01 | 0.135 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.334165e-01 | 0.135 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.358290e-01 | 0.133 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.358290e-01 | 0.133 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.410758e-01 | 0.130 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.410758e-01 | 0.130 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.410758e-01 | 0.130 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.410758e-01 | 0.130 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.410758e-01 | 0.130 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.410758e-01 | 0.130 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.426086e-01 | 0.129 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.426086e-01 | 0.129 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.488276e-01 | 0.126 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.488276e-01 | 0.126 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.570281e-01 | 0.121 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.574494e-01 | 0.121 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.574494e-01 | 0.121 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.574494e-01 | 0.121 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.574494e-01 | 0.121 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.574494e-01 | 0.121 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.574494e-01 | 0.121 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.574494e-01 | 0.121 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.574494e-01 | 0.121 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.574494e-01 | 0.121 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.583201e-01 | 0.120 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.583201e-01 | 0.120 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.583201e-01 | 0.120 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.583201e-01 | 0.120 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.707879e-01 | 0.113 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.707879e-01 | 0.113 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.707879e-01 | 0.113 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.733437e-01 | 0.112 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.745611e-01 | 0.111 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.745611e-01 | 0.111 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.745611e-01 | 0.111 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.748164e-01 | 0.111 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.748164e-01 | 0.111 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.767290e-01 | 0.110 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.793171e-01 | 0.108 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.793171e-01 | 0.108 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.793171e-01 | 0.108 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.793171e-01 | 0.108 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.793171e-01 | 0.108 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.793171e-01 | 0.108 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.793171e-01 | 0.108 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.793171e-01 | 0.108 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.793171e-01 | 0.108 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.793171e-01 | 0.108 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.793171e-01 | 0.108 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.793171e-01 | 0.108 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.793171e-01 | 0.108 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.793171e-01 | 0.108 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.793171e-01 | 0.108 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.793171e-01 | 0.108 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.887069e-01 | 0.103 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.898395e-01 | 0.102 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.898395e-01 | 0.102 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.898395e-01 | 0.102 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.898395e-01 | 0.102 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.898395e-01 | 0.102 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.959353e-01 | 0.099 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.963922e-01 | 0.099 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.986491e-01 | 0.098 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.992144e-01 | 0.097 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.992144e-01 | 0.097 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.992144e-01 | 0.097 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.992144e-01 | 0.097 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.992144e-01 | 0.097 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.992144e-01 | 0.097 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.992144e-01 | 0.097 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.992144e-01 | 0.097 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.992144e-01 | 0.097 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.041969e-01 | 0.095 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.041969e-01 | 0.095 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.041969e-01 | 0.095 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.041969e-01 | 0.095 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.082715e-01 | 0.092 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.082715e-01 | 0.092 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.082715e-01 | 0.092 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.173188e-01 | 0.088 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.173188e-01 | 0.088 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.173188e-01 | 0.088 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.173188e-01 | 0.088 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.173188e-01 | 0.088 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.173188e-01 | 0.088 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.173188e-01 | 0.088 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.173188e-01 | 0.088 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.173188e-01 | 0.088 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.173188e-01 | 0.088 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.176750e-01 | 0.087 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.176750e-01 | 0.087 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.176750e-01 | 0.087 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.176750e-01 | 0.087 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.195602e-01 | 0.086 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.195602e-01 | 0.086 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.195602e-01 | 0.086 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.195602e-01 | 0.086 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.195602e-01 | 0.086 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.195602e-01 | 0.086 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.263788e-01 | 0.083 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.269862e-01 | 0.083 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.281671e-01 | 0.082 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.294579e-01 | 0.081 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.302778e-01 | 0.081 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.302778e-01 | 0.081 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.303156e-01 | 0.081 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.303156e-01 | 0.081 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.303156e-01 | 0.081 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.337917e-01 | 0.079 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.337917e-01 | 0.079 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.337917e-01 | 0.079 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.337917e-01 | 0.079 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.337917e-01 | 0.079 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.337917e-01 | 0.079 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.337917e-01 | 0.079 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.337917e-01 | 0.079 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.337917e-01 | 0.079 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.337917e-01 | 0.079 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.337917e-01 | 0.079 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.337917e-01 | 0.079 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.337917e-01 | 0.079 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.404440e-01 | 0.075 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.404440e-01 | 0.075 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.404440e-01 | 0.075 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.404440e-01 | 0.075 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.421602e-01 | 0.075 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.421602e-01 | 0.075 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.421602e-01 | 0.075 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.421602e-01 | 0.075 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.454443e-01 | 0.073 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.464089e-01 | 0.072 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 8.487801e-01 | 0.071 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.487801e-01 | 0.071 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.487801e-01 | 0.071 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.532494e-01 | 0.069 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.532494e-01 | 0.069 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.532494e-01 | 0.069 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.532494e-01 | 0.069 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.577642e-01 | 0.067 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.621617e-01 | 0.064 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.624177e-01 | 0.064 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.624177e-01 | 0.064 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.624177e-01 | 0.064 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.624177e-01 | 0.064 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.624177e-01 | 0.064 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.624177e-01 | 0.064 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.636232e-01 | 0.064 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.636232e-01 | 0.064 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.636232e-01 | 0.064 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.733203e-01 | 0.059 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.733203e-01 | 0.059 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.733203e-01 | 0.059 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.748261e-01 | 0.058 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.759964e-01 | 0.057 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.759964e-01 | 0.057 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.823785e-01 | 0.054 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.823785e-01 | 0.054 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.829499e-01 | 0.054 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.829499e-01 | 0.054 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.837112e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.851143e-01 | 0.053 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.861161e-01 | 0.053 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.861161e-01 | 0.053 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 8.861161e-01 | 0.053 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.861161e-01 | 0.053 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.861161e-01 | 0.053 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.861161e-01 | 0.053 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.861161e-01 | 0.053 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.861161e-01 | 0.053 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.875341e-01 | 0.052 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.878557e-01 | 0.052 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.895615e-01 | 0.051 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.895615e-01 | 0.051 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.908339e-01 | 0.050 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.908339e-01 | 0.050 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.908339e-01 | 0.050 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.911109e-01 | 0.050 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.930351e-01 | 0.049 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.958440e-01 | 0.048 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.963884e-01 | 0.048 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.963884e-01 | 0.048 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.963884e-01 | 0.048 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.963884e-01 | 0.048 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.963884e-01 | 0.048 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.963884e-01 | 0.048 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.963884e-01 | 0.048 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.963884e-01 | 0.048 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.963884e-01 | 0.048 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.978625e-01 | 0.047 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.987217e-01 | 0.046 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.987217e-01 | 0.046 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.987217e-01 | 0.046 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.987217e-01 | 0.046 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.987217e-01 | 0.046 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.987217e-01 | 0.046 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.057347e-01 | 0.043 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.057347e-01 | 0.043 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.057347e-01 | 0.043 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.057347e-01 | 0.043 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.057347e-01 | 0.043 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.057347e-01 | 0.043 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.057347e-01 | 0.043 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.057347e-01 | 0.043 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.057347e-01 | 0.043 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.057347e-01 | 0.043 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.057347e-01 | 0.043 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.060754e-01 | 0.043 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.060754e-01 | 0.043 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.104438e-01 | 0.041 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.129146e-01 | 0.040 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.129272e-01 | 0.040 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.129272e-01 | 0.040 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.129272e-01 | 0.040 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.129272e-01 | 0.040 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.141972e-01 | 0.039 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.142384e-01 | 0.039 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.142384e-01 | 0.039 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.142384e-01 | 0.039 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.142384e-01 | 0.039 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.142384e-01 | 0.039 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.142384e-01 | 0.039 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.142384e-01 | 0.039 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.216015e-01 | 0.035 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.216015e-01 | 0.035 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.219755e-01 | 0.035 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.219755e-01 | 0.035 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.219755e-01 | 0.035 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.219755e-01 | 0.035 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.219755e-01 | 0.035 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.219755e-01 | 0.035 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.219755e-01 | 0.035 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.219755e-01 | 0.035 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.240876e-01 | 0.034 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.252462e-01 | 0.034 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.252462e-01 | 0.034 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.252533e-01 | 0.034 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.263027e-01 | 0.033 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.263027e-01 | 0.033 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.266899e-01 | 0.033 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.273222e-01 | 0.033 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.276198e-01 | 0.033 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.286435e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.290150e-01 | 0.032 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.290150e-01 | 0.032 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.290150e-01 | 0.032 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.290150e-01 | 0.032 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.290150e-01 | 0.032 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.290150e-01 | 0.032 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.323240e-01 | 0.030 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.349199e-01 | 0.029 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.354197e-01 | 0.029 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.354197e-01 | 0.029 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.354197e-01 | 0.029 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.354197e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.354197e-01 | 0.029 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.354197e-01 | 0.029 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.354197e-01 | 0.029 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.401891e-01 | 0.027 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.412469e-01 | 0.026 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.412469e-01 | 0.026 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.412469e-01 | 0.026 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.412469e-01 | 0.026 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.412469e-01 | 0.026 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.421167e-01 | 0.026 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.432487e-01 | 0.025 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.436652e-01 | 0.025 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.441510e-01 | 0.025 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.446839e-01 | 0.025 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.447535e-01 | 0.025 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.451147e-01 | 0.025 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.465486e-01 | 0.024 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.465486e-01 | 0.024 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.465486e-01 | 0.024 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.465486e-01 | 0.024 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.465486e-01 | 0.024 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.465486e-01 | 0.024 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.465486e-01 | 0.024 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.465486e-01 | 0.024 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.478681e-01 | 0.023 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.478681e-01 | 0.023 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.492321e-01 | 0.023 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.492321e-01 | 0.023 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.492321e-01 | 0.023 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.513536e-01 | 0.022 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.513536e-01 | 0.022 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.513722e-01 | 0.022 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.513722e-01 | 0.022 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.513722e-01 | 0.022 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.513722e-01 | 0.022 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.513722e-01 | 0.022 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.513722e-01 | 0.022 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.530269e-01 | 0.021 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.544717e-01 | 0.020 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.557608e-01 | 0.020 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.557608e-01 | 0.020 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.557608e-01 | 0.020 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.565994e-01 | 0.019 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.565994e-01 | 0.019 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.565994e-01 | 0.019 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.576815e-01 | 0.019 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.597535e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.597535e-01 | 0.018 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.597535e-01 | 0.018 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.597535e-01 | 0.018 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.597535e-01 | 0.018 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.597535e-01 | 0.018 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.597535e-01 | 0.018 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.598877e-01 | 0.018 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.605480e-01 | 0.017 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.612321e-01 | 0.017 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.629363e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.633861e-01 | 0.016 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.633861e-01 | 0.016 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.633861e-01 | 0.016 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.657420e-01 | 0.015 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.657420e-01 | 0.015 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.663039e-01 | 0.015 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.666910e-01 | 0.015 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.666910e-01 | 0.015 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.666910e-01 | 0.015 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.666910e-01 | 0.015 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.680904e-01 | 0.014 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.720157e-01 | 0.012 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.724333e-01 | 0.012 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.729433e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.730474e-01 | 0.012 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.749221e-01 | 0.011 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.749221e-01 | 0.011 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.751247e-01 | 0.011 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.771862e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.771862e-01 | 0.010 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.771862e-01 | 0.010 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.777179e-01 | 0.010 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.785467e-01 | 0.009 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.792461e-01 | 0.009 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.792461e-01 | 0.009 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.792461e-01 | 0.009 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.792782e-01 | 0.009 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.807340e-01 | 0.008 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.811201e-01 | 0.008 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.811201e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.811201e-01 | 0.008 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.819887e-01 | 0.008 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.828250e-01 | 0.008 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.843760e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.845161e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.846917e-01 | 0.007 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.857871e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.857871e-01 | 0.006 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.866563e-01 | 0.006 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.866618e-01 | 0.006 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.869984e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.870707e-01 | 0.006 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.870707e-01 | 0.006 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.875837e-01 | 0.005 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.880211e-01 | 0.005 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.880211e-01 | 0.005 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.882385e-01 | 0.005 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.889652e-01 | 0.005 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.896831e-01 | 0.005 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.902674e-01 | 0.004 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.902674e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.902674e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.902674e-01 | 0.004 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.911467e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.914440e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.919465e-01 | 0.004 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.919465e-01 | 0.004 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.919465e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.926741e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.926741e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.932792e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.932792e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.933361e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.936727e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.936727e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.944860e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.945108e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.947653e-01 | 0.002 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.949843e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.951850e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.953647e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.953647e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.954376e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.962251e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.962556e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.965948e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.965948e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.968487e-01 | 0.001 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.973269e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.976753e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.978621e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.980268e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.983242e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.983912e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.983912e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.985367e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.985367e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.987894e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.988989e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.989533e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.990209e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.990872e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.990892e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.991716e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.991716e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.992377e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.992428e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.992465e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.993505e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.993767e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.994331e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.994331e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.995658e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997082e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997346e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.997346e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998055e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.998208e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998349e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998639e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998770e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998848e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998898e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999195e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999318e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999349e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999422e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999463e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999603e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999710e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999765e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999853e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999941e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999949e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999973e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999977e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999977e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999980e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999980e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999981e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999987e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999988e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999988e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999996e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |